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ABSTRACT
Barthelemy, Joanna Ph.D., Biomedical Sciences Ph.D. program , Wright State University,
2015. A novel function for FANCJ helicase in microsatellite stabilization during
replication stress.
Noncanonical DNA structure-forming sequences, such as hairpin structures, stall
replication forks in vivo, expand or contract during DNA replication, and colocalize with
chromosome fragile sites. Since the frequency of hairpin formation is higher than the
frequency of expansion or contraction, the cell may possess mechanisms to resolve
hairpin structures prior to replication fork stalling. One possible activity for hairpin
resolution is the FANCJ DNA helicase, known to unwind noncanoncial DNA structures
in vitro. Indeed, mutations or loss of any of the nineteen FANC genes, including FANCJ,
leads to genome instability and the cancer-prone syndrome Fanconi anemia (FA).
To test whether (CTG)n·(CAG)n trinucleotide repeat (TNR) stability is protected
by FANCJ in human cells, HeLa derived cell lines were created by integration of
cassettes containing the c-myc replication origin and (CTG)n · (CAG)n TNRs. Small pool
PCR was used to assess genome instability after siRNA depletion of FANCJ helicase in
the presence of a replication stress. The results of these experiments indicate FANCJ
helicase is essential for the maintenance of (CTG)n·(CAG)n TNR stability independent of
replication polarity, and DNA double strand breaks (DSBs) occur near (CTG)n·(CAG)n
microsatellites in the absence of FANCJ helicase. These results were confirmed in FA
patients cells null for FANCJ. Remarkably, several other types of microsatellite
sequences capable of forming noncanoncial DNA structures (hairpins, triplexes, Gquadruplexes, unwound DNA) also suffered DSBs in FANCJ depleted cells, indicating a
novel role for FANCJ in microsatellite stabilization across the genome. In contrast, HeLa
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cells depleted for other FANC proteins or patient cells null for other FA proteins did not
show a similar phenotype suggesting FANCJ stabilizes microsatellite sequences apart
from activation of the FA repair pathway.
Genome instability present at microsatellite sequences results in loss of small pool
PCR signal leading us to believe double strand break formation has occurred. We suspect
loss of PCR signal results from unrepaired DSBs or DSBs repaired by a translocation
event to another site along the genome. To understand the mechanism of double strand
break repair at the ectopic site (CTG)·(CAG) trinucleotide repeats, determined by small
pool PCR signal loss, inverse PCR coupled with next generation sequencing was
employed. The results of next generation sequencing revealed that DSBs are occurring at
or near the (CTG)·(CAG) repeats of the ectopic site in cells depleted of FANCJ and
treated with aphidicolin lead to translocations with other sites along the genome. Next
generation sequencing identified chromosomal positions of translocation sites. These
chromosomal positions correspond to cytogenetic positions which have previously been
identified as being associated with chromosome breaks in tumors and cells from patients
with several developmental disorders. These results suggest a role for FANCJ helicase in
cancer and other developmental diseases as a protector of microsatellite stability.
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INTRODUCTION
(CTG)·(CAG) trinucleotide repeats are dynamic DNA sequences
Microsatellites, short repetitive DNA sequences (such as (CTG)·(CAG) repeats),
are prone to form noncanonical DNA structures such as hairpins, triplexes, and Gquadruplexes when DNA is in a single strand conformation (Figure 1) (Collins et al.,
2003; Cooper et al., 2011; Gatchel and Zoghbi, 2005; McMurray, 2010). These structures
pose a threat to proper DNA replication, represent hotspots for chromosomal breakage
and translocations, and increase the potential for genome instability (Cooper et al., 2011;
Gatchel and Zoghbi, 2005; McMurray, 2010; Zeman and Cimprich, 2014). During DNA
metabolism, the structure forming sequence is exposed after unwinding from histones
leading to the formation of non-B DNA structures. The noncanonical DNA structure is
susceptible to DNA damage and evades DNA repair mechanisms resulting in
accumulation of DNA damage (Aguilera and Gomez-Gonzalez, 2008; Glover et al.,
1984; Wang and Vasquez, 2009). Models for noncanonical DNA structures to
accumulate double strand breaks during replication are depicted in Figure 2 (Aguilera and
Gomez-Gonzalez, 2008; Glover et al., 1984). Expansion or contraction in the number of
repeats of the microsatellite and formation of double strand breaks at or near the
repetitive sequence represent consequences of noncanoncial DNA structure formation
and are termed instability (Zeman and Cimprich, 2014). All forms of repeat instability
1

threaten genomic integrity. Genomic aberrations caused by instability of microsatellites
are associated with multiple human diseases.

(CTG)·(CAG) repeat instability association with DM1
(CTG)·(CAG) trinucleotide repeats are one subset of microsatellite sequences.
(CTG)·(CAG) repeat instability has been linked to multiple neurodegenerative disorders
including myotonic dystrophy type1. Myotonic dystrophy type 1 (DM1) refers to a
chronic, systemic disorder affecting approximately 1 in 8,000 individuals worldwide
(Shaw and Harper, 1989). Characteristics of DM1 include muscle wasting, myotonia
(prolonged muscle contractions), cataracts, heart conduction defects, and weakness in the
extremities and face (Shaw and Harper, 1989). The cause of DM1 has been linked to an
expansion of a (CTG)·(CAG) microsatellite, a short repeated DNA sequence, in the
dystrophia myotonica protein kinase (DMPK) gene (Fernandez-Lopez et al., 2004;
McMurray, 2010). (CTG)·(CAG) repeat lengths are categorized into three classes:
normal range (5-37 repeats), pre-mutation (38-49 repeats), and symptomatic disease (≥50
repeats). In affected individuals there is a direct correlation between the length of the
(CTG)·(CAG) repeats and severity of the disease, and an inverse correlation with the age
of disease onset, termed genetic anticipation. The (CTG)·(CAG)repeats are located in the
3’ untranslated region (3’ UTR) of the DMPK gene (Brook et al., 1992). An expansion in
the (CTG)·(CAG) repeats leading to a disease state and the observed phenotypes results
from an accumulation of unprocessed messenger RNA (mRNA) in the nucleus (Roberts
et al., 1997). The large number of (CTG)·(CAG) repeats transcribe into CUG repeats
(Brook et al., 1992; Tiscornia and Mahadevan, 2000). These CUG repeats sequester
splicing proteins, specifically musclebind like protein (MBNL), affecting the proper
2

processing of other pre-mRNAs (Tiscornia and Mahadevan, 2000). Recent research
suggests prevention of proper mRNA processing through altered MBNL levels directly
correlates to myotonia, muscle wasting, and cardiac abnormalities seen in DM1 patients
(Orengo et al., 2008).
Our laboratory previously showed the (CTG)·(CAG) repeats responsible for DM1
form hairpin structures in vivo (Liu et al., 2010). Replication forks move slower and hold
a greater tendency to stall at fragile sites, such as (CTG)·(CAG) repeats (Freudenreich et
al., 1997; Miret et al., 1998; Pelletier et al., 2003). Therefore, understanding the
mechanisms necessary to resolve hairpin structures is of importance.

(CTG)n·(CAG)n DM1 model cell lines
To examine phenotypes of the active (CTG)·(CAG) repeats, we created HeLa
derived cell lines containing a single ectopic copy of (CTG)·(CAG) repeats
(representative of normal (12 repeats), pre-mutation (45 repeats), and disease state (102
repeats)) next to the c-myc replication origin to mimic replication across the
(CTG)·(CAG) repeats at the endogenous DMPK locus (Liu et al., 2010; Liu et al., 2012).
The c-myc replicator acts as a point of reference to map the direction of replication. The
orientation of the (CTG)·(CAG) repeats relative to the c-myc replicator determines which
repeat (CTG or CAG) becomes the template for leading strand synthesis and the
complementary repeat is the template for lagging strand synthesis (Liu et al., 2010). This
model system helped demonstrate that hairpins form during replication, suggesting that
hairpins can form on either the template DNA or nascent DNA during replication and
unresolved hairpins present in the template DNA can lead to contractions while hairpins
3

Figure 1: Possible non-B form structures formed at microsatellites during
replication. (A-D) Schematics of unusual DNA structures formed by repeated
sequences. (CTG)·(CAG) repeats fold into hairpin structures (A) in vivo, DNA fitting
the G4 consensus sequence folds into G-quadruplex structures (B), slip strand
structures can occur at trinucleotide repeats (D), and polypurine·polypyrimidine
sequences can fold back onto itself creating a triplex (C) when DNA is in a single
strand conformation. (Adapted from Cooper et al., 2011)
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Figure 2. Mechanisms for double strand break formation at repetitive DNA
sequences. (A) Hairpin structures are substrates for DNA repair endonucleases,
which create nicks in the DNA at the base of the hairpin. The nicked DNA is then
converted to a double strand break (DSB). (B) Hairpin structures can form on the 5’
end of an Okazaki fragment preventing the activity of the flap endonuclease FEN1
facilitating a cut on the template strand leading to double strand break (DSB)
formation. (C) Hairpin structures can form in both the template (black) and daughter
strand (grey) creating a Holliday junction structure which will be converted to two
hairpin ended molecules that will be further processed by repair proteins into a
double strand break (DSB). Although hairpins are represented in this figure, other
noncanonical DNA structures including triplexes and G-quadruplexes would be
processed in the same manner. (Adapted from Aguilera and Gomez-Gonzalez, 2008)
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Figure 3: Hairpin-induced trinucleotide repeat instability. Using HeLa derived
cell lines containing a single copy of (CTG)·(CAG) repeats, we showed hairpins
form at the trinucleotide repeats during replication and this hairpin formation
induces instability. Hairpin formation on the template strand during replication
causes contractions while hairpin formation on the nascent strand during replication
produces expansions. (Adapted from Liu et al., 2010)
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present in the nascent DNA result in expansions (Figure 3) (Liu et al., 2010). Both
contractions and expansions represent potentially harmful forms of genome instability
(Liu et al., 2012). The mechanism necessary for resolving hairpins and maintaining
genome stability at the (CTG)·(CAG) repeats of the DMPK locus remains unknown.
Since the frequency of hairpin formation is much higher than the frequency of
expansion or contraction, the cell likely possesses mechanisms to resolve hairpin
structures and avoid replication fork stalling. Possible enzymes for hairpin resolution are
DNA helicases known to unwind noncanonical DNA structures. Genome instability
disorders arise from mutations or loss of these helicases including the cancer
predisposition diseases Fanconi anemia (FANCJ helicase) (Litman et al., 2005),
Bloom’s syndrome (BLM helicase) (Ellis et al., 1995), Werner’s syndrome (WRN
helicase) (Yu et al., 1996), and Rothmund-Thomson syndrome (RecQL4 helicase)
(Kitao et al., 1999).

Fanconi anemia (FA) and genome instability
Many different genome instability diseases exist. FA refers to an autosomal
recessive disorder characterized by bone marrow failure, developmental abnormalities,
and cancer predisposition (Deakyne and Mazin, 2011; Kee and D'Andrea, 2010;
Niedernhofer et al., 2005). All FA patients possess severe chromosomal instability
(Deakyne and Mazin, 2011; Niedernhofer et al., 2005). Mutations in one of nineteen
different FA complementation groups, each complementation group represents mutations
in a single FANC protein expressing gene, leads to hypersensitivity to interstrand
crosslinking agents. Initial work categorized a group of eight of genetic complementation
7

Figure 4: Fanconi anemia repair pathway. A schematic of the assembly of FANC
proteins to the site of an inter-strand crosslink for DNA damage repair.
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groups corresponding to a cluster of FANC proteins (FANCA, FANCB, FANCC,
FANCE, FANCF, FANCG, FANCL, FANCM) that aggregate together in response to
damaged DNA (Deakyne and Mazin, 2011; Raschle et al., 2008; Xue et al., 2008).
Recently, an additional core complex protein was identified, the ubiquitin E2 conjugase
UBE2T (FANCT) (Rickman et al., 2015; Virts et al., 2015). After a DNA damaging
event, DNA damage sensing kinases (ATR and ATM) phosphorylate FANCM resulting
in the formation of the FA core complex consisting of these nine FANC proteins
(Raschle et al., 2008; Shigechi et al., 2012). As an E3 ubiquitin ligase, FANCL functions
to monoubiquitinate both phosphorylated FANCI and phosphorylated FANCD2 leading
to FANCI/FANCD2 heterodimerization and translocation of both proteins to the site of
DNA damage creating nuclear foci (Garner and Smogorzewska, 2011; Joo et al., 2011;
Raschle et al., 2008). Subsequently, additional FA proteins travel to the site of DNA
damage including FANCD1 (BRCA2) (Wagner et al., 2004), FANCN (PALB2)
(Tischkowitz and Xia, 2010), activated (phosphorylated) FANCJ (Levitus et al., 2005),
BRCA1 (FANCS) (Sawyer et al., 2015), FANCP (SLX4) (Stoepker et al., 2011),
FANCQ (ERCC4) (Bogliolo et al., 2013), FANCR (RAD51) (Bogliolo and Surralles,
2015; Wang et al., 2015a), and FANCO (RAD51C) (Somyajit et al., 2012). Once
assembled at the site of damaged DNA, DNA repair is initiated (Figure 4). In addition to
resolution of interstrand crosslinks, members of the FA repair pathway are required for
normal DNA replication and the response to replication stress. Therefore, many FA
proteins operate in other DNA repair pathways including nucleotide excision repair
(NER), mismatch repair (MMR), and homologous recombination (HR) (Kee and
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D'Andrea, 2010). Of interest for this work is the function of the FANCJ helicase, which
acts in a number of these replication dependent repair processes.

FANCJ and genome instability
Fanconi anemia completion group J patients share classification as a result of
mutations within the FANCJ gene (Wu et al., 2008). FANCJ was first identified as a
binding partner of the breast cancer type 1 protein (BRCA1) and was referred to as
BRCA1-interacting protein 1 (Brip1) (Cantor et al., 2001; Greenberg et al., 2006).
Further examination of the interaction between FANCJ and BRCA1 revealed that FANCJ
binds to the BRCA1 C-terminal (BRCT) repeat motif found within the C-terminus of
BRCA1 binding partners (Cantor et al., 2001). As previously stated, a subset of FA
patients have mutations within the FANCJ gene and it was later determined FANCJ is
Brip1 (Litman et al., 2005). The FANCJ gene codes for a helicase functioning to unwind
DNA in a 5’ to 3’ orientation (i.e. FANCJ moves 5’ to 3’ along a DNA strand) (London
et al., 2008). FANCJ unwinds noncanonical DNA structures such as G-quadruplexes
(Figure 1b) and DNA repair intermediate structures such as Holliday junctions (London
et al., 2008; Wu et al., 2008). Functioning with the FA repair pathway, FANCJ plays a
role in the protection of genome stability in response to interstrand crosslinking reagents
(Wu et al., 2008; Wu et al., 2009). Recently, the FANCJ analog in C. elegans, dog-1
(Youds et al., 2008), was shown to be crucial for genome stability (Cheung et al., 2002;
Kruisselbrink et al., 2008; Wu et al., 2009). The loss of dog-1 lead to the deletion of G4
DNA, DNA known to fold into G-quadruplex structures, and this deletion began
immediately 5’ of the start of the G4 DNA and ended at random locations hundreds of
nucleotides downstream of the G4 DNA (Cheung et al., 2002; Kruisselbrink et al., 2008).
10

Similar results were seen in chicken cells null for FANCJ (Kitao et al., 2011). The human
homolog of FANCJ interacts with multiple DNA damage responding proteins including
BRCA1, the repair nuclease Mre11, the replication and repair protein TopBP1, the single
strand DNA binding protein RPA, the mismatch repair protein MLH1, and the BLM
helicase. Blocking the interaction of FANCJ with these proteins leads to reduced cell
survival under replicative stress. Additionally, mutations resulting in loss of FANCJ
display similar cellular phenotypes when exposed to replication stress. Recent work has
indicated a role for FANCJ in DNA replication since FANCJ patient cells are
hypersensitive to DNA polymerase inhibitors and interstrand crosslinking reagents
(Levitus et al., 2005; Levran et al., 2005; Litman et al., 2005). Taken together; these
results suggest an essential role for FANCJ in the maintenance of genome stability
through a known function of unwinding noncanonical DNA structures. However, the
exact role FANCJ plays in the protection of genome stability in human systems remains
unknown. Thus, the work described below focuses on understanding the function of
FANCJ in microsatellite stabilization.

11

MATERIALS AND METHODS
Cell Culture
Cell lines were derived from a HeLa acceptor cell line containing a single FRT
(FLP recombinase target) site (HeLa/406 acceptor cell line) on chromosome 18 (Liu et
al., 2003). Acceptor cells were co-transfected with a plasmid expressing FLP
recombinase and a donor plasmid containing (CTG)·(CAG) repeats downstream of the cmyc replicator (integration of the donor plasmid at the FRT site in acceptor lines is
outlined in Figure 5). Donor plasmids are designed such that the direction of replication
from the c-myc origin through the repeats is known allowing for identification of which
repeat (CTG or CAG) acts as leading strand replication template and lagging strand
template for replication. We developed four different cell lines containing varying
numbers of (CTG)·(CAG) repeats representing normal and disease states. Each repeat
was placed next to the c-myc replicator in both the forward and reverse orientation. This
resulted in two separate cell lines for each number of repeats, the repeat (CTG or CAG) is
the template for leading strand synthesis during replication in one cell line and the
template for lagging strand synthesis in the second cell line. Cell lines were named based
on the repeat present in the lagging strand template (Figure 6). (CTG)102/(CAG)102
(disease state) cells will be used in all the following experiments and (CTG)12/(CAG)12
(normal/unaffected) cells will serve as controls, this short repeat length should not be
susceptible to genome instability. FANCJ null (752) and 752 cells complemented with
12

Figure 5: Chromosomal integration of c-myc-(CTG)·(CAG) constructs. A
diagram of stable integration of donor plasmids containing the c-myc replicator
adjacent to varying lengths of (CTG)·(CAG) repeats to create DM1 model cell lines.
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Figure 6: Schematic of donor c-myc-(CTG)·(CAG) donor plasmids. A cartoon
representation of (CTG)·(CAG) donor plasmids. (CTG)·(CAG) repeats are
positioned downstream of c-myc replicator. Cell lines are termed based on the repeat
(CTG or CAG) present in the lagging strand (as indicated in red).
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wild type FANCJ (752+FANCJ WT) (Raghunandan et al., 2015), FANCC, FANCQ, and
FANCI immortalized Fanconi anemia patient cell lines were generously provided by Dr.
Helmut Hanenberg (Heinrich-Heine-Universität Düsseldorf). RA3087 (FANCA),
RA3331 (FANCP), RA2645 (FANCD2), RA3100 (FANCL), RA3226
(FANCD1/BRCA2), and RA2374 (FANCJR798X) immortalized Fanconi anemia patient
fibroblast cell lines were kindly provided by Dr. Agata Smogorzewska (Rockefeller
University) (Kim et al., 2013). Apparently healthy primary fibroblasts (GM08402),
Bloom’s Syndrome primary fibroblasts (GM166860), SV40 transformed fibroblasts
(GM08505), Werner Syndrome primary fibroblasts (AG03141), and SV40 transformed
(AG11395) patient fibroblast cell lines were obtained from Coriell Cell Repositories. All
cell lines were grown in Dulbeco’s modified Eagle’s medium (DMEM) supplemented
with 10% fetal bovine serum at 37°C and 5% CO2.

Aphidicolin/Hydroxyurea treatment of fibroblast cell lines
To promote noncanonical DNA structure formation, DM1 model cell lines were
treated with reagents known to slow replication progression in conjunction with knock
down of proteins of interest. Aphidicolin (APH), a DNA polymerase inhibitor, was used
to slow replication (~30-50%) at a concentration (0.2 μM) which will not initiate an acute
DNA checkpoint response (Casper et al., 2002; Glover et al., 1984; Wist, 1980). To test
whether the results obtained from aphidicolin experiments are drug specific, similar
experiments were performed in the presence of low dose (0.3 mM) hydroxyurea (HU),
which also slows replication fork movement leading to upregulation of ribonucleotide
reductase and firing of dormant replication origins without acutely activating the
checkpoint response (Chen et al., 2015; Petermann et al., 2010). In contrast to
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aphidicolin, HU is a ribonucleotide reductase inhibitor. Treatment with these replication
slowing reagents should enhance possible DNA secondary structure formation at
microsatellite sequences. All experiments were performed with and without replication
slowing reagents in conjunction with siRNA against proteins of interest or the control
siRNA. (CTG)n·(CAG)n cells were given 0.2 μM APH or 0.3mM HU for a total of 10
days. Fibroblast cell lines were treated with 0.5 μM APH or 0.3 mM HU for 10 days.
Control, untreated counterparts were plated simultaneously. Cells were harvested on the
tenth day of treatment using TrypLE ™ Express (Life Technologies 12604), a trypsin
alternative.

siRNA Treatment
(CTG)n·(CAG)n cells at a confluency of 60% were reversely transfected with
siPort NeoFX transfection reagent (Invitrogen 4510M) and 100 nM (final concentration)
of small interfering RNA (siRNA) pool (an equal molar mixture of 4 different siRNAs
targeting the same transcript) (Dharmacon Research, Inc.) targeting FANCJ/Brip1
(siGENOME SMARTpool M-010587), FANCM (siGENOME SMARTpool M-021955),
FANCD2 (siGENOME SMARTpool M-016376), BLM (siGENOME SMARTpool M007287), or WRN (siGENOME SMARTpool M-010378) in a six-well plate every 48
hours for a total of five transfections in the presence of aphidicolin or hydroxyurea. Cells
were harvested using TrypLE ™ Express (Life Technologies) 48 hours post the fifth
transfection. Control experiments were carried out in parallel using AllStars negative
nontargeting siRNA (Qiagen SI03650318).
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PCR
Small pool PCR (spPCR). After cells were treated with siRNA and replication
slowing reagents, DNA was isolated from cells using an E.Z.N.A ® Tissue DNA Kit
from Omega Bio-Tek (D3396). PCR was performed on a small amount (~1-10 genome
equivalents) of DNA template (50 pg of genomic DNA) per reaction. Four small pool
PCR (spPCR) reactions were performed on DNA template from each experimental
condition. All spPCR reactions occurred in the presence of HotStart Taq polymerase
MasterMix (Qiagen 203443) and amplification conditions were 95°C (15 min); 35 cycles
of 94°C (1 min), 54°C (45 s), 72°C (1 min); and final extension at 72°C (7 min). PCR
products were resolved in 8% polyacrylaminde gels. GelRed (Biotium 41002) stained
gels were imaged using a Fuji LAS-3000 and the software ImageReader.
Inverse PCR (iPCR). Samples were derived from CTG102 cell DNA treated
simultaneously with siFANCJ (5 transfections) and aphidicolin (0.2 μM). DNA (2.5 ug)
was digested with an excess of MseI (New England BioLabs, Inc. R0525) for 1 hour at
37°C in a 50μL total volume reaction. After a 20 minute heat inactivation at 65°C, 10 μL
of the restriction digest reaction was used for ligation. Ligation occurred in the presence
of T4 DNA ligase (New England BioLabs, Inc. M0202) for 1 hour at 16°C. The ligation
reaction product was cleaned using the MinElute Reaction Cleanup Kit (Qiagen 28204).
Amplification of ligation products occurred using iPCR primers (iPCR forward primer:
5’ CATGCTGTCCAGGCAGGTAGATGA 3’ and iPCR reverse primer: 5’
CCGGAACGCAGAAGAATCATAATGGG 3’) with HotStart Taq polymerase
mastermix (conditions: 15 min at 95°C; 35 cycles of 1 min at 94°C, 45s at 58°C, 1 min at
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Table 1. Small pool PCR primer pairs used in this work. Primer sets used for
spPCR to examine instability of repeated sequences and internal controls.
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72°C; 7 min at 72°C). iPCR products were cleaned using the MinElute Reaction Cleanup (Qiagen 28204) and used for next generation sequencing.
A list of primers used in this work can be found in Table 1.

Western Blotting
Whole cell lysates from treated or untreated HeLa cells and fibroblast cells were
prepared with Mammalian Protein Extraction Reagent (M-PER) (Thermo Scientific
78501) and protease inhibitor cocktail (Sigma P8340). After SDS-PAGE and transfer to a
polyvinylidene fluoride (PVDF) membrane (ThermoFisher Scientific 88518), membranes
were probed using a 1:500 dilution of primary antibody (rabbit FANCJ/Brip1 (Abcam
ab151509), mouse FANCM (Dr. Lei Li, University of Texas MD Anderson Cancer
Center) (Wang et al., 2013), mouse FANCD2 (Santa Cruz Biotechnology, Inc. SC20022), rabbit BLM-7099 (Dr. Jan Karlseder, The Salk Institute for Biological Studies)
(Orazio et al., 2011), mouse WRN (Abcam ab66606) and mouse β-actin (Sigma-Aldrich
A5441)) overnight at 4°C. After incubation with the corresponding horseradish
peroxidase (HRP) conjugated secondary antibody at a dilution of 1:1000 at room
temperature for 1 hour, membranes were imaged on a Fuji LAS-3000 using
ImageReader.

Aphidicolin Sensitivity
Using a reverse transfection approach, CAG102 cells were transfected with FANCJ
or control siRNA every 48 hours. Continuous aphidicolin (0.2 μM) treatment began 24
hours post the first transfection (0 hr) for a total of 96 hours. Fibroblast cells were treated
continuously with aphidicolin (0.5 μM) for 96 hours. Treated cells were harvested using
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TrypLE ™ Express (Life Technologies) and viable cells were counted every 24 hours
using trypan blue (Sigma-Aldrich T8154) exclusion.

Flow Cytometry
FANCJ null fibroblast cells were treated with 0.5 μM aphidicolin for a total of 10
days. Treated cells were collected and fixed in cold 70% ethanol for 10 minutes at room
temperature. After washing with PBS and 5mM EDTA (3X; 15 minutes per wash), cells
were incubated with propidium iodide (PI) (Sigma-Aldrich P4170) for 30 minutes.
Stained cells were analyzed by flow cytometry.

Next Generation Sequencing
The Case Western Reserve University Genomics Care facility performed next
generation sequencing analysis on iPCR products of DNA from CTG102 cells treated with
FANCJ siRNA and aphidicolin.
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RESULTS

I. FANCJ is essential for microsatellite stabilization
FANCJ is necessary for CTG102·CAG102 trinucleotide repeat stability
Through interaction with multiple proteins known to respond to noncanonical
DNA structures and replication stress, FANCJ must play a critical role in DNA
replication. Noncanonical DNA structures known to slow replication forks include
CTG·CAG hairpins, G-quadruplexes, and asymmetric purine·pyrimidine (Pu·Py) repeat
tracts able to form DNA triplexes (H-DNA). Previous work has shown that
(CTG)102·(CAG)102 microsatellites form hairpins in vivo and stall replication forks (Liu et
al., 2010). Since FANCJ unwinds DNA structures responsible for inhibition of DNA
replication and (CTG)102·(CAG)102 repeats form hairpin structures in vivo, we wanted to
examine the effect of loss of FANCJ helicase on (CTG)102·(CAG)102 repeat stability.
HeLa-derived cell lines harboring a single ectopic copy of CTG102·CAG102
trinucleotide repeats (TNRs) directly downstream of the c-myc core replicator were
created (Figure 7A). During replication, the CTG102 or CAG102 repeat serves as lagging
strand template in its respective cell line. A pool of siRNAs was used to knockdown
FANCJ (Figure 7B) in the absence (control) or presence of a low dose of aphidicolin (0.2
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Figure 7. FANCJ knockdown leads to loss of ectopic (CTG)·(CAG)
microsatellite signal in (CTG)102·(CAG)102 cells treated with aphidicolin. (A)
Diagram of the integration site in (CAG)102·(CTG)102 cell lines. (B) Whole cell
extracts were isolated after treatment of cells with siRNA against FANCJ and
aphidicolin for a total of five transfections, or parallel untreated cultures, and
immunoblotted for FANCJ. (C) Small pool PCR results with primers flanking the
ectopic (CAG)102·(CTG)102 repeats and primers for a site without microsatellites, an
internal control for proper function of the PCR machinery.
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μM APH) that slows DNA polymerases (~30-50%) and reveals chromosome fragile sites
without activating the DNA checkpoint response in CTG102·CAG102 cells (Casper et al.,
2002; Glover et al., 1984; Wist, 1980). Non-targeting siRNA was used as a control.
Duplex small pool PCR (spPCR) analysis of genomic DNA was performed with an
internal control primer set to assess differences between cells in the population and detect
expansions, contractions, or breaks (instability) of the microsatellite sequences. spPCR
results from CTG102 and CAG102 cells showed a dramatic decrease in PCR signal at the
ectopic site (CTG)·(CAG) repeats in CTG102·CAG102 cells after loss of FANCJ in the
presence of APH (Figure 7C). However, spPCR of sequences 1-3 kb upstream or
downstream of the (CTG)·(CAG) repeats of the ectopic site did not exhibit instability
(Figure 8). In addition to CTG102·CAG102 cells, CTG12·CAG12 cells were constructed.
Twelve repeats are indicative of a normal range of repeats. Similar to the CTG102·CAG102
cells, CTG12·CAG12 cells were depleted of FANCJ using siRNA (Figure 9B) and treated
with APH. Surprisingly, we observed in cells treated with both siFANCJ and APH, PCR
signal of the (CTG)·(CAG) ectopic site repeats was diminished compared to control cells
(Figure 9C) suggesting FANCJ is essential for (CTG)·(CAG) trinucleotide repeat
stability even at nonpathological repeat lengths.
As a control to link genome instability to the (CTG)·(CAG) trinucleotide repeats
at the ectopic site, we created an additional HeLa derived cell line in which the
(CTG)·(CAG) repeats were replaced with a nonrepetitive sequence at the integration site
(Figure 10A). Depletion of FANCJ in the presence of aphidicolin in these cells did not
result in microsatellite instability at the ectopic site (Figure 10B) confirming
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Figure 8. FANCJ knockdown leads does not lead to spPCR signal loss 1-3kb
upstream and downstream of (CTG)·(CAG) repeats. (A, B) Small pool PCR
results with primers ~1kb upstream of the ectopic (CTG)·(CAG)

repeats and

primers for an internal control. (C, D) Small pool PCR results with primers ~3kb
downstream of the ectopic (CTG)·(CAG)
control.
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repeats and primers for an internal

Figure 9. FANCJ knockdown leads to loss of ectopic (CTG)·(CAG)
microsatellite signal in (CTG)12·(CAG)12 cells treated with aphidicolin. (A)
Diagram of the integration site in (CAG)12·(CTG)12 cell lines. (B) Whole cell
extracts were isolated after treatment of cells with siRNA against FANCJ and
aphidicolin for a total of five transfections, or parallel untreated cultures, and
Western blotted for FANCJ. (C) Small pool PCR results with primers flanking the
ectopic (CAG)12·(CTG)12 repeats and primers for an internal control site.
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Figure 10. FANCJ knockdown does not lead to spPCR signal loss at a
nonrepetitive sequence of the ectopic site. Small pool PCR results with primers
flanking the nonrepetitive sequence at the ectopic site and primers for an internal
control.
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microsatellite instability is occurring due to the (CTG)·(CAG) repeats present at the
ectopic site. Therefore, the ectopic site does not indiscriminately induce instability.
Small pool PCR is an end-point PCR method which can lead to an over estimate
of a low abundance template compared to a higher abundant template that has plateaued
amplification early in the PCR. To determine the sensitivity of our assay, we titrated
CTG102 DNA, containing one ectopic site copy and four internal control site copies, with
increasing amounts of HeLa DNA (four internal control site copies, no ectopic site
copies) (Figure 11). A four-fold dilution of the ectopic copy by the internal control copy
was easily detected (Figure 11). Therefore, we conclude the loss of PCR signal in cells
treated with FANCJ knockdown and APH treatment represents the loss or separation of
primer binding sites flanking the (CTG)·(CAG) repeats in a large majority (≥ 75%) of the
cell population.
CTG102·CAG102 cells were also treated with hydroxyurea (0.3 mM HU), a
ribonucleotide reductase inhibitor, to deplete dNTP pools and inhibit DNA replication
(Chen et al., 2015; Petermann et al., 2010). This low dose of HU slows replication forks
and activates dormant origins to promote cell survival without initiating a DNA
checkpoint response (Chen et al., 2015; Petermann et al., 2010). spPCR results revealed a
loss of PCR signal at the ectopic site CTG102·CAG102 repeats in cells that had been
treated with FANCJ siRNA and HU (Figure 12). Taken together, these results suggest a
role for FANCJ in the maintenance of (CTG)·(CAG) trinucleotide repeat stability during
replicative stress (APH or HU) independent of (CTG)·(CAG) repeat replication polarity.
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Figure 11. Titration of CTG102 cell DNA with HeLa cell DNA. Small pool PCR
results of CTG102 cell DNA (1 ectopic site copy and 4 internal control site copies)
was mixed with varying concentrations of HeLa DNA (4 internal control site copies
and no ectopic site copies) resulting in template ratios of ectopic site: internal control
of 1:4, 1:8, 1:16, 1:32.
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Figure 12. FANCJ knockdown leads to loss of ectopic (CTG)·(CAG)
microsatellite signal in (CTG)102·(CAG)102 cells treated with hydroxyurea. (A)
Diagram of the integration site in (CAG)102·(CTG)102 cell lines. (B) Whole cell
extracts were isolated after treatment of cells with siRNA against FANCJ and
hydroxyurea for a total of five transfections, or parallel untreated cultures, and
immunoblotted for FANCJ. (C) Small pool PCR results with primers flanking the
ectopic (CAG)102·(CTG)102 repeats and primers for a site without microsatellites
serving as an internal control.
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Figure 13: Expandable repeats associated with human disease. A schematic of
microsatellites responsible for human disease and the corresponding location along
the gene affected by the expansion of these repeated sequences.
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FANCJ is necessary for endogenous microsatellite repeat stability
Trinucleotide repeats examined in preliminary experiments are only one class of
microsatellites associated with disease (Collins et al., 2003). About 3% of the human
genome consists of microsatellites, although not all of these microsatellites cause disease
(Subramanian et al., 2003). Other types of disease associated microsatellites include tetranucleotide repeats, penta-nucleotide repeats, mirror repeats, and other trinucleotide
repeated sequences (Figure 13) (Collins et al., 2003; McMurray, 2010; Subramanian et
al., 2003). Since FANCJ works to protect the stability of (CTG)·(CAG) trinucleotide
repeats; FANCJ may also have a function in the prevention of instability at other disease
related microsatellites. To determine if this function of FANCJ is unique to
(CTG)·(CAG) trinucleotide repeats, we examined multiple endogenous loci of different
repeat composition. First, we confirmed (CTG)·(CAG) trinucleotide repeat stabilization
by FANCJ with the analysis of the endogenous (CTG)·(CAG) repeats of the dystrophia
myotonica protein kinase (DMPK, chr 19q13.32) gene, spinocerebellar ataxia type 1
(SCA1, chr 6p22.3) gene, transcription factor 4 (TCF4, chr 18q21.2) gene (referred to
also as CTG18.1), and expanded repeat domain 1 (ERDA1, chr q21.3) loci. As observed
for the ectopic site (CTG)·(CAG) repeat, the spPCR results from CAG102 cells depleted
of FANCJ and treated with APH showed PCR signal loss at these endogenous loci
(Figure 14). Next, we examined the effect of loss of FANCJ during replicative stress
(APH) on other non-(CTG)·(CAG) disease associated loci including the penta-nucleotide
ATTCT repeat of the spinocerebellar ataxia type 10 (SCA10, chr22q13.31) locus, and the
polypurine·polypyrimidine (Pu·Py) repeat track (thought to form triplexes and/or Gquadruplexes) of the polycystic kidney disease 1 (PKD1, chr 16p13.3, autosomal
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Figure 14. FANCJ knockdown leads to the loss PCR signal at multiple
endogenous microsatellites with aphidicolin treatment. Small pool PCR results
from endogenous DMPK (CTG repeat), SCA10 (ATTCT repeat), PKD1 (Pu·Py
mirror repeat), α-1B tubulin (G4 DNA, G-quadruplex), ERDA1 (CTG repeat), SCA1
(CTG repeat), β-globin (G4 DNA), TCF4 (CTG repeat), FANCJ/BRIP1 (polyT
repeat), c-MYC (G4 DNA), p53 (poly T repeat), and p63 (poly T repeat) in cells
treated with siFANCJ or siControl and aphidicolin.
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Figure 14 (continued). FANCJ knockdown leads to the loss PCR signal at
multiple endogenous microsatellites with aphidicolin treatment. Small pool PCR
results from endogenous DMPK (CTG repeat), SCA10 (ATTCT repeat), PKD1
(Pu·Py mirror repeat), α-1B tubulin (G4 DNA, G-quadruplex), ERDA1 (CTG
repeat), SCA1 (CTG repeat), β-globin (G4 DNA), TCF4 (CTG repeat),
FANCJ/BRIP1 (polyT repeat), c-MYC (G4 DNA), p53 (poly T repeat), and p63
(poly T repeat) in cells treated with siFANCJ or siControl and aphidicolin.
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Figure 15. FANCJ knockdown leads to the loss PCR signal at multiple
endogenous microsatellites with hydroxyurea treatment. Small pool PCR results
from endogenous DMPK (CTG repeat), SCA10 (ATTCT repeat), PKD1 (Pu·Py
mirror repeat), α-1B tubulin (G4 DNA, G-quadruplex), ERDA1 (CTG repeat), SCA1
(CTG repeat), β-globin (G4 DNA), TCF4 (CTG repeat), FANCJ/BRIP1 (polyT
repeat), c-MYC (G4 DNA), p53 (poly T repeat), and p63 (poly T repeat) in cells
treated with siFANCJ or siControl and hydroxyurea.
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Figure 15 (continued). FANCJ knockdown leads to the loss PCR signal at
multiple endogenous microsatellites with hydroxyurea treatment. Small pool
PCR results from endogenous DMPK (CTG repeat), SCA10 (ATTCT repeat), PKD1
(Pu·Py mirror repeat), α-1B tubulin (G4 DNA, G-quadruplex), ERDA1 (CTG
repeat), SCA1 (CTG repeat), β-globin (G4 DNA), TCF4 (CTG repeat),
FANCJ/BRIP1 (polyT repeat), c-MYC (G4 DNA), p53 (poly T repeat), and p63
(poly T repeat) in cells treated with siFANCJ or siControl and hydroxyurea.
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dominant polycystic kidney disease). These additional disease associated microsatellite
sequences examined vary in nucleotide composition, length, and location throughout the
genome. Treatment of CAG102 cells with FANCJ siRNA and APH lead to spPCR results
displaying a loss of PCR signal at all endogenous microsatellites analyzed (Figure 14).
Additionally, we examined repeat sequences which are not associated with a
microsatellite disorder including a mono-nucleotide poly T repeat in p63 (chr 3q28),
FANCJ/BRIP1 (17q23.2), and p53 (chr 17p13.1), as well as G4 DNA (known to form Gquadruplexes) of β-globin (chr 11p15.4), α-1B tubulin (chr 12q13.12), and c-MYC (chr
8q24.21). In the absence of FANCJ and presence of APH, a loss of PCR signal was
observed in CAG102 cells. Similar results were obtained from spPCR results of CAG102
cells depleted of FANCJ and treated with HU, in which all endogenous microsatellites
examined showed a loss of PCR signal (Figure 15). Since the loss of PCR signal is not
specific to (CTG)·(CAG) repeat tracks, we conclude FANCJ is essential for the
stabilization of microsatellites across the genome during replicative stress irrespective of
nucleotide composition and length.
To account for possible off-target effects of siRNA treatment, immortalized
Fanconi anemia complementation group J patient fibroblasts (FANCJ null) harboring a
biallelic frameshift mutation (c.308delG, p.F103fs) were treated with aphidicolin (0.5 μM
APH). spPCR analysis of all the endogenous microsatellites previously tested revealed a
dramatic loss of PCR signal compared to internal controls (Figure 16). FANCJ null cells
treated with HU also displayed PCR signal loss (Figure 17) further strengthening our
finding that replication stress causes microsatellite instability in FANCJ null or depleted
cells during replication stress.
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While performing APH treatment of FANCJ knocked down and null cells, we
noticed a hypersensitivity to the APH compared to control cells. We counted CAG102
cells treated with FANCJ or control siRNA in APH as well as FANCJ null, wild-type and
FANCA null fibroblast cells treated with APH and confirmed a decrease in the relative
cell number of FANCJ knocked down or null cells (Figure 18).
Next we sought to determine if the phenotype of PCR signal loss at endogenous
microsatellite sequences could be rescued with the expression of FANCJ wild-type
cDNA. As expected, expression of wild-type FANCJ cDNA (Figure 19) in FANCJ null
cells treated with APH (Figure 20) or HU (Figure 21) recovered spPCR signal loss at all
tested endogenous microsatellite sequences.
Although the dose of aphidicolin used in these experiments has previously been
shown to slow replication fork progress without activating the DNA checkpoint response,
the spPCR signal loss seems too dramatic to remain under the detection of the checkpoint
response. Therefore, we examined the cell cycle profiles of FANCJ null cells treated with
0.5 μM APH at different time points using the DNA stain propidium iodide and flow
cytometry. Starting as early as 2 days of treatment with APH, FANCJ null cells begin to
arrest in G2/M when compared to untreated control cells (Figure 22). Coupled with the
robust loss of PCR signaling at microsatellites, we conclude that double strand breaks
occur at microsatellites eventually causing a DNA checkpoint response and delayed cell
division.

Summary
The presented data suggest a novel role for the DNA helicase FANCJ in
microsatellite stabilization across the genome during replicative stress. To begin we
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Figure 16. FANCJ null cells show loss of microsatellite signals after treatment
with aphidicolin. Small pool PCR across endogenous microsatellite sites using
DNA from FANCJ null cells treated with aphidicolin.
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Figure 16 (continued). FANCJ null cells show loss of microsatellite signals after
treatment with aphidicolin. Small pool PCR across endogenous microsatellite sites
using DNA from FANCJ null cells treated with aphidicolin.
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Figure 17. FANCJ null cells show loss of microsatellite signals after treatment
with hydroxyurea. Small pool PCR across endogenous microsatellite sites using
DNA from FANCJ null cells treated with hydroxyurea.
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Figure 17 (continued). FANCJ null cells show loss of microsatellite signals after
treatment with hydroxyurea. Small pool PCR across endogenous microsatellite
sites using DNA from FANCJ null cells treated with hydroxyurea.
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Figure 18. FANCJ depleted cells are hypersensitive to aphidicolin. (A) CAG102
cells treated with control of FANCJ siRNA and aphidicolin for 96 hours and counted
every 24 hours. (B) FANCJ null, FANCA null, FANCJR798X, and wild-type
fibroblast cells treated with aphidicolin continuously for 96 hours and counted every
24 hours.
42

Figure 19. Expression of FANCJ wild-type cDNA in FANCJ null cells. Whole
cell lysates of FANCJ null, FANCJ null complimented with FANCJ wild-type
cDNA, and HeLa cells probed for FANCJ protein.
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Figure 20. Aphidicolin treatment of FANCJ null +FANCJ WT cDNA cells.
Small pool PCR results for all endogenous microsatellites in FANCJ null cells
complimented with FANCJ wild-type cDNA treated with aphidicolin.
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Figure 20 (continued). Aphidicolin treatment of FANCJ null +FANCJ WT
cDNA cells. Small pool PCR results for all endogenous microsatellites in FANCJ
null cells complimented with FANCJ wild-type cDNA treated with aphidicolin.
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Figure 21. Hydroxyurea treatment of FANCJ null +FANCJ WT cDNA cells.
Small pool PCR results for all endogenous microsatellites in FANCJ null cells
complimented with FANCJ wild-type cDNA treated with hydroxyurea.
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Figure 21 (continued). Hydroxyurea treatment of FANCJ null +FANCJ WT
cDNA cells. Small pool PCR results for all endogenous microsatellites in FANCJ
null cells complimented with FANCJ wild-type cDNA treated with hydroxyurea.
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Figure 22. Cell cycle profiles of FANCJ null cells treated with aphidicolin. (A)
Propidium iodide DNA stained FANCJ null cells analyzed by flow cytometry after
2, 4, 6, 8, or 10 days of aphidicolin treatment. (B) Composite of cell cycle profiles.
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showed (CTG)·(CAG) trinucleotide repeat instability at an ectopic site integrated into the
HeLa genome in the absence of FANCJ and presence of either APH or HU. However, as
shown by evaluation of multiple endogenous microsatellite sequences in CAG102 cells
treated with FANCJ siRNA and APH or HU by spPCR, the function of FANCJ in
microsatellite stabilization has broad effects. These results were confirmed with the
treatment of FANCJ null cells with APH or HU. Lastly, expression of wild-type FANCJ
cDNA in FANCJ null cells rescued the effects of APH or HU treatment establishing a
direct relationship between FANCJ and microsatellite instability during replicative stress.

II. FANCJ functions independently of the FA repair pathway
FA repair pathway activity is not necessary for microsatellite stabilization by
FANCJ
The helicase FANCJ plays a role in the replication dependent Fanconi anemia
(FA) repair pathway (Kee and D'Andrea, 2010). Classical models of the FA repair
pathway imply a function to resolve interstrand crosslinks (Kee and D'Andrea, 2010).
However, recent literature suggests a broader role for the FA repair pathway in the
resolution of other types of DNA damage including double strand breaks (DSBs) (Kee
and D'Andrea, 2010). The presence of an interstrand crosslink within DNA activates a
signaling cascade beginning with the phosphorylation of FANCM followed by the
assembly of a core complex, consisting 9 other FANC proteins (Kee and D'Andrea,
2010). Once the core complex assembles, the E3 ubiquitin ligase, FANCL, becomes
active and monoubiquitinates both FANCD2 and FANCI leading to heterodimer
formation of FANCI and FANCD2 and localization of both proteins at the site of the
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interstrand crosslink (Garner and Smogorzewska, 2011; Kee and D'Andrea, 2010).
Subsequently, downstream effectors, including the helicase FANCJ, localize to the
damaged DNA for repair to occur (Kee and D'Andrea, 2010). The activation of the FA
repair pathway is depicted in Figure 3. Since the loss of FANCJ coupled with aphidicolin
treatment causes instability at a variety of microsatellite sequences producing double
strand breaks, FANCJ may work in conjunction with the entire FA pathway to play a role
in genome stabilization. To determine if the activation of the FA repair pathway is
required for FANCJ to maintain microsatellite stability, we first knocked down the
initiator protein of the pathway, FANCM, with a pool of siRNAs in CTG102·CAG102 cells
with and without APH (Figure 23). Results for spPCR experiments using primers
flanking the ectopic site (CTG)·(CAG) repeats revealed no loss of PCR signal in contrast
to cells treated with siFANCJ and APH. In addition, all of the endogenous microsatellites
previously examined also showed no loss of PCR signal in the absence of FANCM and
presence of APH (Figure 24) suggesting FANCJ functions independent of FANCM
phosphorylation to maintain microsatellite stability.
To determine the requirement of FA core complex assembly on FANCJ stabilized
microsatellites, immortalized FANCA, FANCC, and FANCL null patient cells lines were
obtained. FA core complex cell lines were treated with either APH or HU for 10 days as
were immortalized wild-type fibroblast cells as a control. FANCA (Figure 25 and 26),
FANCC (Figure 27 and 28), FANCL (Figure 29 and 30) null APH or HU treated cells
produced spPCR products in which no loss of PCR signal was observed at any
endogenous microsatellite analyzed. Likewise, no microsatellite instability was observed
in wild-type fibroblast cells treated with aphidicolin (Figure 31) or hydroxyurea (Figure
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Figure 23. FANCM knockdown does not lead to loss of ectopic (CTG)·(CAG)
microsatellite signal in (CTG)102·(CAG)102 cells treated with aphidicolin. (A)
Diagram of the integration site in (CAG)102·(CTG)102 cell lines. (B) Whole cell
extracts were isolated after treatment of cells with siRNA against FANCM and
aphidicolin for a total of five transfections, or parallel untreated cultures, and
immunoblotted for FANCM. (C) Small pool PCR results with primers flanking the
ectopic (CAG)102·(CTG)102 repeats and primers for a site without microsatellites
serving as an internal control.
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Figure 24. FANCM knockdown does not lead to loss of PCR signal at multiple
endogenous sites with aphidicolin treatment. Small pool PCR results of CAG102
cells treated with siFANCM and aphidicolin. No loss of PCR signal was observed at
multiple endogenous microsatellites.
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Figure 24 (continued). FANCM knockdown does not lead to loss of PCR signal
at multiple endogenous sites with aphidicolin treatment. Small pool PCR results
of CAG102 cells treated with siFANCM and aphidicolin. No loss of PCR signal was
observed at multiple endogenous microsatellites.
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Figure 25. Aphidicolin treatment of FANCA nulls cells. Multiple endogenous
microsatellites were examined via small pool PCR after aphidicolin treatment in
FANCA null cells.
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Figure 25 (continued). Aphidicolin treatment of FANCA nulls cells. Multiple
endogenous microsatellites were examined via small pool PCR after aphidicolin
treatment in FANCA null cells.
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Figure 26. Hydroxyurea treatment of FANCA nulls cells. Multiple endogenous
microsatellites were examined via small pool PCR after hydroxyurea treatment in
FANCA null cells.
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Figure 26 (continued). Hydroxyurea treatment of FANCA nulls cells. Multiple
endogenous microsatellites were examined via small pool PCR after hydroxyurea
treatment in FANCA null cells.
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Figure 27. Aphidicolin treatment of FANCC nulls cells. Small pool PCR across
repeated sequence loci in FANCC null cells treated with aphidicolin.

58

Figure 27 (continued). Aphidicolin treatment of FANCC nulls cells. Small pool
PCR across repeated sequence loci in FANCC null cells treated with aphidicolin.
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Figure 28. Hydroxyurea treatment of FANCC nulls cells. Small pool PCR across
repeated sequence loci in FANCC null cells treated with hydroxyurea.
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Figure 28 (continued). Hydroxyurea treatment of FANCC nulls cells. Small pool
PCR across repeated sequence loci in FANCC null cells treated with hydroxyurea.
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Figure 29. Aphidicolin treatment of FANCL nulls cells. Multiple endogenous
microsatellites were examined via small pool PCR after aphidicolin treatment in
FANCL null cells.
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Figure 29 (continued). Aphidicolin treatment of FANCL nulls cells. Multiple
endogenous microsatellites were examined via small pool PCR after aphidicolin
treatment in FANCL null cells.
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Figure 30. Hydroxyurea treatment of FANCL nulls cells. Multiple endogenous
microsatellites were examined via small pool PCR after hydroxyurea treatment in
FANCL null cells.
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Figure 30 (continued). Hydroxyurea treatment of FANCL nulls cells. Multiple
endogenous microsatellites were examined via small pool PCR after hydroxyurea
treatment in FANCL null cells.
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Figure 31. Aphidicolin treatment of immortalized wild-type fibroblast cells.
Small pool PCR across repeated sequence in DNA from immortalized wild-type
fibroblast cells treated with or without aphidicolin.
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Figure 31 (continued). Aphidicolin treatment of immortalized wild-type
fibroblast cells. Small pool PCR across repeated sequence in DNA from
immortalized wild-type fibroblast cells treated with or without aphidicolin.
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Figure 32. Hydroxyurea treatment of immortalized wild-type fibroblast cells.
Small pool PCR across repeated sequence in DNA from immortalized wild-type
fibroblast cells treated with or without hydroxyurea.
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Figure 32 (continued). Hydroxyurea treatment of wild-type fibroblast cells.
Small pool PCR across repeated sequence in DNA from wild-type fibroblast cells
treated with or without hydroxyurea.
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33). These data support the conclusion that FANCJ stabilizes microsatellite sequences
regardless of FA core complex assembly.
The signal for FANCJ recruitment to the site of DNA damage during a FA repair
pathway response is heterodimer formation of monoubiquitinated FANCD2 and FANCI.
Knockdown of FANCD2 using a pool of four siRNAs in CTG102·CAG102 cells treated
with aphidicolin did not lead to a loss of PCR signal at either the (CTG)·(CAG) ectopic
site repeats (Figure 33) or endogenous microsatellites (Figure 34) suggesting FANCJ
works independently of the FA repair pathway to stabilize microsatellite sequences.
These results were confirmed in immortalized FANCD2 null patient cells treated with
APH (Figure 35) or HU (Figure 36). In addition, immortalized FANCI null cells were
treated with either APH (Figure 37) or HU (Figure 38). Examination of endogenous
microsatellite sequences with spPCR showed no loss of PCR signal indicating FANCJ
maintains microsatellite stability independent of FANCD2 and FANCI hetereodimer
formation.
FANCJ is a downstream effector of the FA repair pathway. Other downstream
effectors of the FA repair pathway participate in other DNA repair pathways including
homologous recombination. We sought to determine if microsatellite stabilization is a
function of these proteins as well. FANCP/SLX4 (Figure 39 and 40), FANCQ/ERCC4
(Figure 41 and 42), and FANCD1/BRCA2 (Figure 43 and 44) immortalized patient
fibroblasts were subjected to replicative stress (APH or HU). Microsatellite instability
was not detected in these cells after replication stress implying FANCJ has a unique role
in microsatellite stabilization.
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Figure 33. FANCD2 knockdown does not lead to loss of ectopic (CTG)·(CAG)
microsatellite signal in (CTG)102·(CAG)102 cells treated with aphidicolin. (A)
Diagram of the integration site in (CAG)102·(CTG)102 cell lines. (B) Whole cell
extracts were isolated after treatment of cells with siRNA against FANCD2 and
aphidicolin for a total of five transfections, or parallel untreated cultures, and
immunoblotted for FANC D2. (C) Small pool PCR results with primers flanking the
ectopic (CAG)102·(CTG)102 repeats and primers for a site without microsatellites
serving as an internal control.
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Figure 34. FANCD2 knockdown does not lead to loss of PCR signal at multiple
endogenous sites with aphidicolin treatment. Small pool PCR results of CAG102
cells treated with siFANCD2 and aphidicolin showing no patterns of instability at
multiple endogenous microsatellites.
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Figure 34 (continued). FANCD2 knockdown does not lead to loss of PCR signal
at multiple endogenous sites with aphidicolin treatment. Small pool PCR results
of CAG102 cells treated with siFANCD2 and aphidicolin showing no patterns of
instability at multiple endogenous microsatellites.
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Figure 35. Aphidicolin treatment of FANCD2 null cells. Small pool PCR results
of DNA from FANCD2 null patient fibroblast cells treated with aphidicolin.
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Figure 35 (continued). Aphidicolin treatment of FANCD2 null cells. Small pool
PCR results of DNA from FANCD2 null patient fibroblast cells treated with
aphidicolin.
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Figure 36. Hydroxyurea treatment of FANCD2 null cells. Small pool PCR
results of DNA from FANCD2 null patient fibroblast cells treated with hydroxyurea.
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Figure 36 (continued). Hydroxyurea treatment of FANCD2 null cells. Small
pool PCR results of DNA from FANCD2 null patient fibroblast cells treated with
hydroxyurea.
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Figure 37. Aphidicolin treatment of FANCI null cells. Small pool PCR across
repeated sequences in DNA from FANCI null patient fibroblast cells treated with
aphidicolin.
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Figure 37 (continued). Aphidicolin treatment of FANCI null cells. Small pool
PCR across repeated sequences in DNA from FANCI null patient fibroblast cells
treated with aphidicolin.
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Figure 38. Hydroxyurea treatment of FANCI null cells. Small pool PCR across
repeated sequences in DNA from FANCI null patient fibroblast cells treated with
hydroxyurea.
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Figure 38 (continued). Hydroxyurea treatment of FANCI null cells. Small pool
PCR across repeated sequences in DNA from FANCI null patient fibroblast cells
treated with hydroxyurea.
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Figure 39. FANCP null cells do not show microsatellite signal loss treated
with aphidicolin.

Small pool PCR across repeated sequences in DNA from

FANCP null patient fibroblast cells treated with aphidicolin.
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Figure 39 (continued). FANCP null cells do not show microsatellite signal loss
treated with aphidicolin. Small pool PCR across repeated sequences in DNA from
FANCP null patient fibroblast cells treated with aphidicolin.
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Figure 40. FANCP null cells do not show microsatellite signal loss treated with
hydroxyurea. Small pool PCR across repeated sequences in DNA from FANCP
null patient fibroblast cells treated with hydroxyurea.
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Figure 40 (continued). FANCP null cells do not show microsatellite signal loss
treated with hydroxyurea. Small pool PCR across repeated sequences in DNA
from FANCP null patient fibroblast cells treated with hydroxyurea.
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Figure 41. FANCQ null cells do not show microsatellite signal loss treated with
aphidicolin. Small pool PCR results from FANCQ null patient fibroblast cells
treated with aphidicolin.
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Figure 41 (continued). FANCQ null cells do not show microsatellite signal loss
treated with aphidicolin.

Small pool PCR results from FANCQ null patient

fibroblast cells treated with aphidicolin.
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Figure 42. FANCQ null cells do not show microsatellite signal loss treated with
hydroxyurea. Small pool PCR results from FANCQ null patient fibroblast cells
treated with hydroxyurea.
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Figure 42 (continued). FANCQ null cells do not show microsatellite signal loss
treated with hydroxyurea. Small pool PCR results from FANCQ null patient
fibroblast cells treated with hydroxyurea.
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Figure 43. FANCD1 null cells do not show microsatellite signal loss treated with
aphidicolin. Small pool PCR across repeated sequence loci from FANCD1 null
patient fibroblast cells treated with aphidicolin.
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Figure 43 (continued). FANCD1 null cells do not show microsatellite signal loss
treated with aphidicolin. Small pool PCR across repeated sequence loci from
FANCD1 null patient fibroblast cells treated with aphidicolin.
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Figure 44. FANCD1 null cells do not show microsatellite signal loss treated with
hydroxyurea. Small pool PCR across repeated sequence loci from FANCD1 null
patient fibroblast cells treated with hydroxyurea.
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Figure 44 (continued). FANCD1 null cells do not show microsatellite signal loss
treated with hydroxyurea. Small pool PCR across repeated sequence loci from
FANCD1 null patient fibroblast cells treated with hydroxyurea.
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Summary
Taken together, these results indicate microsatellite stabilization by FANCJ
occurs independently of the activity of the other FA repair pathway proteins. We
examined each step of the FA repair pathway (activation, core complex assembly,
heterodimer formation and recruitment of downstream effectors) individually through the
treatment of FANC null patient fibroblast cells with replicative stress (APH or HU).
Results of these experiments confirmed the novel function of FANCJ in microsatellite
stabilization occurs independently FA repair pathway function.

III. Loss of FANCJ with APH treatment leads to DSBs and subsequent

translocations
Determination of sites along the genome recombined with the ectopic site
(CTG)·(CAG) in the absence of FANCJ
The data presented above show a loss of a PCR signal when small pool PCR is
performed with primers flanking the ectopic site (CTG)·(CAG) repeats in DM1 model
cells treated with siRNA against FANCJ and aphidicolin or hydroxyurea (Figure 7 and
12). These data suggest that the PCR primer binding sites have been separated in cells
depleted of FANCJ under replicative stress. However, sequences both upstream and
downstream of the (CTG)·(CAG) repeats are still intact (Figure 8). Standard PCR
primers were designed to obtain a PCR product extending from the known upstream site
to the known downstream site across the (CTG)·(CAG) repeats (Figure 45A). DNA
samples from (CAG)102 (DM1 model) cells treated with both siRNA targeting FANCJ
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Figure 45: PCR of the ectopic site in DM1 model cells. (A) A map of the PCR
primer set used to amplify from the known upstream sequence to the known
downstream through the (CTG)·(CAG) repeats (arrowheads). (B) PCR results using
primers shown in (A).
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and aphidicolin failed to produce a standard PCR product using these primers (Figure
45B) further confirming that the upstream and downstream sequences of the ectopic site
are no longer within close proximity to one another. We believe a double strand break has
occurred at or near the ectopic site (CTG)·(CAG) repeats (within 100bp flanking the
repeat since the PCR primers used for spPCR bind 100bp upstream and downstream of
the trinucleotide repeats produce loss of PCR signal) leading to recombination of the
(CTG)·(CAG) repeats with unknown sites along the genome. To understand the
mechanism by which PCR primer binding sites of the ectopic site are separated, we
utilized a MseI endonuclease cut site (located near the ectopic site (CTG)·(CAG)
repeats), a map of the ectopic site including MseI cut sites is shown in (Figure 46),
coupled with intramolecular ligation to create circularized DNA containing known
ectopic site sequence and unknown genomic DNA (Figure 46). To amplify only DNA
sequences of interest, PCR amplification was performed using inverse PCR (iPCR)
primers (Figure 46) targeting ectopic site sequences still present after treatment with both
siRNA against FANCJ and aphidicolin. PCR products were separated on an agarose gel;
a representative image is shown in Figure 47B. PCR products appeared as a smear on the
agarose gel (Figure 47B) indicating multiple sites along the genome recombined with the
ectopic (CTG)·(CAG) repeats, size variations (leading to multiple bands on the agarose
gel “smear”) occur based upon the closest MseI recognition sequence at the unknown
genomic site. If recombination had not occurred, a single band would be present on the
gel, representative of the distance between both MseI sites flanking the (CTG)·(CAG)
repeats of the ectopic site (as seen in control DNA digested with MseI and circularized
(Figure 47B). We used next generation sequencing (NGS) to create
96

Figure 46: Schematic of experimental design for inverse PCR. (A) A map of the
ectopic site (white bar) recombining with an unknown sequence in the genome
(black bar). (B) A schematic of the translocation byproduct containing a section of
known ectopic site sequence and unknown genomic sequence. Also denoted are
MseI cut sites (known at the ectopic site and approximated in the unknown
sequence). (C) Circular DNA products after MseI digestion and ligation. (D)
Amplification of circularized genomic DNA with reverse PCR primers (arrowheads
in (B)). Inverse PCR products containing known ectopic site sequence and unknown
genomic sequence, these PCR products were used for next generation sequencing.
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Figure 47: iPCR of CAG102 cells. (A) A map of the approach to produce inverse
PCR product. (B) Represent agarose gel of inverse PCR products.
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Figure 48. Translocation sites identified by next generation sequencing.
Cytogenetic locations of DNA sequencing reads containing translocation junctions.
[bars represent log2(read copy number)]
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Table 2. Microsatellite sequences associated with translocation sites. Majority of
the translocation sites identified by next generation sequencing had a microsatellite
present in close proximity.
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Table 3. Cytogenetic sites are associated with cancer and developmental
disorders. All cytogenetic positions mapped to the translocation sites are associated
with cancer or developmental disease.
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a PCR amplicon library and determine which sites along the genome recombined near the
ectopic (CTG)·(CAG) repeats at the ectopic site in (CAG)102 cells treated with FANCJ
siRNA and aphidicolin.
NGS data confirmed translocations had occurred between the ectopic site and
unknown genomic sites. Approximately 28,000 of the reads from the sequencer contained
translocation junctions between the ectopic site and other chromosomes (Figure 48).
These translocations appear to have occurred nonrandomly. A large majority of
translocations occurred between the ectopic site located on chromosome 18 and the
endogenous c-myc locus on chromosome 8q24.21 via nonallelic homologous
recombination (NAHR). In addition, recombination occurred with the endogenous
(CTG)20 of the DMPK locus (chromosome 19q13.32) further suggesting the ectopic site
is a substrate for NAHR. Microsatellite sequences were observed in close proximity to
the translocation junction of the identified chromosome sites further supporting
translocations occur via nonrandom recombination (Table 2). Although, translocation
sites without microhomology to the ectopic site were also observed. Lastly, the
cytogenetic positions of the translocation sites have previously been associated with a
wide array of the cancers, developmental disorders, and developmental disorders with
predisposition to cancer (Table 3).

Summary
The data presented focuses on understanding the mechanisms that lead to loss of
PCR signal in cells depleted of FANCJ under replicative stress. We utilized an iPCR
approach to amplify MseI digested genomic DNA containing sequences of the ectopic
site present after treatment with FANCJ siRNA and aphidicolin. Next generation
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sequencing identified genomic chromosomal sites fused with the (CTG)·(CAG) ectopic
site sequences. We conclude that replication stress induces double strand breaks resulting
in nonrandom chromosome translocations in FANCJ depleted cells.

IV. FANCJ stabilizes microsatellites independently of BLM/WRN
function
In addition to Fanconi anemia, several other genome instability associated
diseases exist including Bloom’s Syndrome and Werner’s Syndrome. Bloom’s Syndrome
(BS) is an autosomal recessive disease derived from mutations in the BLM (Bloom)
helicase (German, 1995). Similarly, Werner’s Syndrome (WS), also an autosomal
recessive disease, results from mutations within the WRN (Werner) helicase (Holliday et
al., 1974). BLM helicase functions to unwind noncanonical DNA structures to protect
against sister chromatid exchanges and subsequent DNA damage (Li et al., 2001;
Mohaghegh et al., 2001). Recent evidence suggests that BLM works in conjunction with
the FA repair pathway to resolve replication stress and maintain chromosome stability
(Deans and West, 2009; Suhasini and Brosh, 2012; Suhasini et al., 2011). Moreover,
FANCM, the initiator protein of the FA repair pathway contains two separate binding
domains: one for FA repair pathway activation and a second for the recruitment of the
BLM complex (Deans and West, 2009). More recently, it was shown that BLM helicase
and FANCJ directly interact and are functionally linked (Suhasini et al., 2011). BLM
unwinds DNA in a 3’ to 5’ orientation and FANCJ helicase unwinds DNA in a 5’ to 3’
direction (Li et al., 2001; Suhasini et al., 2011). Additionally, a direct relationship
between protein level of BLM helicase and FANCJ helicase exists, BLM helicase protein
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levels are decreased in FANCJ helicase depleted cells (Suhasini et al., 2011). Evidence
exists suggesting that BLM helicase and FANCJ helicase work in concert to maintain
genome stability by unwinding DNA in opposite orientations (Suhasini et al., 2011). In
comparison, WRN helicase also unwinds noncanonical DNA structures to protect
telomeres and prevent pre-mature aging, a hallmark of WS (Li et al., 2001; Mohaghegh et
al., 2001). Current research implies a role for WRN helicase in the stability of fragile
sites as evidenced by the accumulation of gaps and breaks in DNA at common fragile
sites after aphidicolin treatment of WS (WRN null) patient fibroblasts compared to
control normal fibroblast cells treated with aphidicolin (Pirzio et al., 2008). Additionally,
in vitro work with human nuclear extracts and (CTG)·(CAG) containing plasmids
showed WRN is necessary for resolving large CTG/CTG hairpins (Chan et al., 2012).
Most recently, WRN has been shown to compensate for loss of the Fanconi anemia repair
pathway in the protection against genome instability after mitomycin C (MMC) treatment
(Aggarwal et al., 2013). Our data indicates a role for FANCJ in the protection of
microsatellite stability; thus it is possible that interactions between BLM/WRN and
FANCJ may also be necessary for the stability of trinucleotide repeats. A model for
collaboration between FANCJ and BLM/WRN to maintain genome stability is depicted
in Figure 49.

FANCJ can function independently of BLM helicase activity
To understand the role BLM helicase may have in conjunction with FANCJ to
maintain microsatellite stability, we knocked down BLM helicase using a pool of four
siRNAs in CTG102·CAG102 cells (Figure 50B) and exposed them to the replicative
stressor aphidicolin. Cells depleted of BLM and treated with APH did not show
104

Figure 49: FANCJ works in conjunction with WRN or BLM to unwind
secondary DNA structures. A proposed model for FANCJ to collaborate with
WRN or BLM helicase to unwind non-B form structures simultaneously on the
leading template (WRN or BLM) and lagging template (FANCJ) (A) or the same
noncanonical DNA structure (B) for error-free DNA replication.
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Figure 50. BLM knockdown does not lead to loss of ectopic (CTG)·(CAG)
microsatellite signal in (CTG)102·(CAG)102 cells treated with aphidicolin. (A)
Diagram of the integration site in (CAG)102·(CTG)102 cell lines. (B) Whole cell
extracts were isolated after treatment of cells with siRNA against BLM and
aphidicolin for a total of five transfections, or parallel untreated cultures, and
immunoblotted for BLM. (C) Small pool PCR results with primers flanking the
ectopic (CAG)102·(CTG)102 repeats and primers for a site without microsatellites
serving as an internal control.
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Figure 51. BLM knockdown does not lead to loss of PCR signal at multiple
endogenous sites with aphidicolin treatment. Small pool PCR results of CAG102
cells treated with siBLM and aphidicolin showing no patterns of instability at
multiple endogenous microsatellites.
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Figure 51 (continued). BLM knockdown does not lead to loss of PCR signal at
multiple endogenous sites with aphidicolin treatment. Small pool PCR results of
CAG102 cells treated with siBLM and aphidicolin showing no patterns of instability
at multiple endogenous microsatellites.
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Figure 52. BLM null cells exposed to aphidicolin. Small pool PCR results for
DNA from BLM null patient cells treated with aphidicolin.
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Figure 52 (continued). BLM null cells exposed to aphidicolin. Small pool PCR
results for DNA from BLM null patient cells treated with aphidicolin.
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Figure 53. BLM null cells exposed to hydroxyurea. Small pool PCR results for
DNA from BLM null patient cells treated with hydroxyurea.
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Figure 53 (continued). BLM null cells exposed to hydroxyurea. Small pool PCR
results for DNA from BLM null patient cells treated with hydroxyurea.
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Figure 54. WRN knockdown does not lead to loss of ectopic (CTG)·(CAG)
microsatellite signal in (CTG)102·(CAG)102 cells treated with aphidicolin. (A)
Diagram of the integration site in (CAG)102·(CTG)102 cell lines. (B) Whole cell
extracts were isolated after treatment of cells with siRNA against WRN helicase and
aphidicolin for a total of five transfections, or parallel untreated cultures, and
immunoblotted for BLM. (C) Small pool PCR results with primers flanking the
ectopic (CAG)102·(CTG)102 repeats and primers for a site without microsatellites.
serving as an internal control.
113

microsatellite instability (loss of spPCR signal) at the ectopic site (CTG)·(CAG) repeats
(Figure 50C) and endogenous microsatellites (Figure 51). spPCR results were confirmed
in primary Bloom’s Syndrome patient fibroblast cells (BLM null) treated with
aphidicolin (Figure 52) or hydroxyurea (Figure 53) suggesting BLM helicase activity is
dispensable for FANCJ to stabilize microsatellite sequences.

FANCJ can function independently of WRN helicase activity
Similarly, we examined the requirement of WRN activity for microsatellite
stabilization by FANCJ. CTG102·CAG102 cells were depleted of WRN helicase with a
pool of siRNAs (Figure 54B) and treated with aphidicolin. DNA isolated from cells
treated with both WRN siRNA and aphidicolin showed a similar pattern of spPCR
products compared to control counterparts at the ectopic site (CTG)·(CAG) repeats
(Figure 54C) and endogenous microsatellites (Figure 55), in contrast to spPCR products
produced from CTG102·CAG102 cells treated with FANCJ siRNA and aphidicolin (Figure
7). Lack of spPCR signal loss at endogenous microsatellite sequences was confirmed in
primary Werner’s Syndrome patient cells exposed to aphidicolin (Figure 56) and
hydroxyurea (Figure 57) to induce replication stress signifying WRN helicase function is
expendable for FANCJ to maintain microsatellite stability.
A normal primary fibroblast cell line was treated with aphidicolin (Figure 58) or
hydroxyurea (Figure 59) as a control for primary BLM helicase null and primary WRN
helicase null cell lines exposed to replicative stress. Under both conditions, no loss of
PCR signal at endogenous microsatellite sequences was observed.
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Figure 55. WRN knockdown does not lead to loss of PCR signal at multiple
endogenous sites with aphidicolin treatment. Small pool PCR results of CAG102
cells treated with siWRN and aphidicolin showing no patterns of instability at
multiple endogenous microsatellites.
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Figure 55 (continued). WRN knockdown does not lead to loss of PCR signal at
multiple endogenous sites with aphidicolin treatment. Small pool PCR results of
CAG102 cells treated with siWRN and aphidicolin showing no patterns of instability
at multiple endogenous microsatellites.
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Figure 56. Aphidicolin treatment of WRN null patient cells. Small pool PCR
across repeated sequences in DNA from WRN null patient cells treated with
aphidicolin.
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Figure 56 (continued). Aphidicolin treatment of WRN null patient cells. Small
pool PCR across repeated sequences in DNA from WRN null patient cells treated
with aphidicolin.
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Figure 57. Hydroxyurea treatment of WRN null patient cells. Small pool PCR
across repeated sequences in DNA from WRN null patient cells treated with
hydroxyurea.
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Figure 57 (continued). Hydroxyurea treatment of WRN null patient cells. Small
pool PCR across repeated sequences in DNA from WRN null patient cells treated
with hydroxyurea.
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Primary wild-type cells

Figure 58. Primary normal fibroblast cells treated with aphidicolin. Small pool
PCR across repeated sequences in DNA from primary normal fibroblasts treated
with aphidicolin.
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Primary wild-type cells

Figure 58 (continued). Primary normal fibroblast cells treated with aphidicolin.
Small pool PCR across repeated sequences in DNA from primary normal fibroblasts
treated with aphidicolin.
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Primary wild-type cells

Figure 59. Primary normal fibroblast cells treated with hydroxyurea. Small
pool PCR across repeated sequences in DNA from primary normal fibroblasts
treated with hydroxyurea.
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Primary wild-type cells

Figure 59 (continued). Primary normal fibroblast cells treated with
hydroxyurea. Small pool PCR across repeated sequences in DNA from primary
normal fibroblasts treated with hydroxyurea.
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Summary
The present data focus on understanding the potential roles for BLM helicase or
WRN helicase in FANCJ microsatellite stabilization. Recent studies have indicated a
cooperative effort between FANCJ and BLM/WRN helicase to maintain genome
integrity. First, we examined the effect of loss of BLM helicase on microsatellite
stability. Replicative stress does not lead to loss of spPCR signal at the ectopic site
(CTG)·(CAG) repeats and endogenous microsatellites in BLM helicase depleted cells
suggesting BLM helicase activity is nonessential for FANCJ to stabilize microsatellites.
Similarly, induction of replicative stress in WRN depleted and null cells did result in loss
of spPCR signal indicating WRN helicase is dispensable for FANCJ mediated
microsatellite stabilization. Taken together, these results suggest FANCJ can function in
the absence of BLM helicase or WRN helicase to maintain microsatellite stability.

V. FANCJ mutagenesis
FANCJ stabilizes microsatellites independent of BRCA1, TopBP1 and BLM
interaction
Work presented above demonstrates a role for FANCJ in the maintenance of
genome stability (Figure 7). However, the domain(s) necessary for this function of
FANCJ remain(s) unknown. Towards characterizing this role we obtained an
immortalized Faconi anemia complementation group J patient cell line expressing a
biallelic mutant of FANCJ (FANCJR798X). This mutation results in an arginine switch to a
premature stop codon. The protein product of the mutagenized gene eliminates the
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Figure 60: Schematic of FANCJ protein. FANCJ consists of a helicase (comprised
of 7 helicase domains, BRCA1 binding domain, TopBP1 binding domain, RPA
binding domain, BLM binding domain, MLH1 binding domain, iron-sulfur cluster
(Fe-S) and nuclear localization signal. (Wu and Brosh, 2009)

126

Figure 61. FANCJR798X mutant cells are insensitive to microsatellite loss with
aphidicolin treatment. Small pool PCR across endogenous repeated sequences in
DAN from biallelic FANCJR798X patient fibroblasts with aphidicolin.
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Figure 61 (continued). FANCJR798X mutant cells are insensitive to microsatellite
loss with aphidicolin treatment. Small pool PCR across endogenous repeated
sequences in DAN from biallelic FANCJR798X patient fibroblasts with aphidicolin.
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Figure 62. FANCJR798X mutant cells are insensitive to microsatellite loss with
hydroxyurea treatment. Small pool PCR across endogenous repeated sequences in
DAN from biallelic FANCJR798X patient fibroblasts with hydroxyurea.
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Figure 62 (continued). FANCJR798X mutant cells are insensitive to microsatellite
loss with hydroxyurea treatment. Small pool PCR across endogenous repeated
sequences in DAN from biallelic FANCJR798X patient fibroblasts with hydroxyurea.
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following previously identified functional domains: BRCA1 binding domain, TopBP1
binding domain, and BLM helicase binding domain (Figure 60). Recent research suggests
each domain is necessary to allow FANCJ to function properly to unwind noncanonical
DNA structures and promote genome stability in the presence of interstrand crosslinking
agents (Cantor et al., 2001; Gong et al., 2010; Greenberg et al., 2006; Leung et al., 2011;
Suhasini and Brosh, 2012; Suhasini et al., 2011). Therefore, it is feasible that these
domains are essential for FANCJ to function as a protector of microsatellite stability. In
addition, in vitro analysis of FANCJR798X recombinant protein isolated from Sf9 insect
cells shows a loss of helicase activity with this mutation (London et al., 2008). To
determine if these domains of FANCJ are essential for microsatellite stabilization, we
treated FANCJR798X cells with either aphidicolin (Figure 61) or hydroxyurea (Figure 62)
to induce replication stress and examined microsatellite stability via spPCR. PCR
products revealed no loss of signal at endogenous microsatellite sequences, in contrast to
FANCJ null cells exposed to replicative stress. If these domains were necessary for
FANCJ to maintain microsatellite stability, similar patterns of instability would be
observed in the FANCJR798X (Figure 61 and 62) and FANCJ (Figure 16 and 17) null cells.
Since no instability was observed in FANCJR798X cells treated with aphidicolin or
hydroxyurea, we conclude that the BRCA1, TopBP1, and BLM helicase binding domains
are not required for FANCJ to stabilize microsatellites across the genome during
replicative stress.

Summary
The experiments performed above aim to determine which domains of FANCJ are
required for FANCJ to stabilize microsatellite sequences under replicative stress
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conditions. Immortalized Fanconi anemia patient cells harboring a truncation mutation of
FANCJ (FANCJR798X) abolishing BRCA1, TopBP1, and BLM helicase interacting
domains were exposed to replicative stress. spPCR results showed no patterns of
microsatellite instability indicating these domains are nonessential for FANCJ to stabilize
microsatellite sequences.
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DISCUSSION
The data presented here suggest a novel role for FANCJ helicase in the protection
of microsatellite stability. Although FANCJ is known to unwind DNA G-quadruplex and
triplex structures, it was not clear whether this activity extended to other noncanoncial
DNA structures or was important in vivo. Here, we show in vivo in human cells that
FANCJ helicase is essential to stabilize microsatellites prone to adopt noncanoncial DNA
structures during replication stress. This unique function of FANCJ occurs independently
of the FA repair pathway, irrespective of BLM helicase and WRN helicase activity, and
without the interaction sites for BRCA1 or TopBP1.

FANCJ helicase in (CTG)·(CAG) repeat stability
Expansions of the (CTG)·(CAG) repeats in the 3’ untranslated region of the
DMPK gene cause several of the phenotypes associated with DM1 on a cellular level. In
cell models, expansion or contraction of the (CTG)·(CAG) trinucleotide repeats can be
induced with cycles of replication stress followed by recovery (Liu et al., 2012). The data
presented here shows (CTG)·(CAG) repeats are sites of chromosome fragility with the
depletion of FANCJ helicase in the presence of continuous replication stress, as might be
experienced in vivo. Hence, the knockdown of FANCJ helicase in (CTG)102·(CAG)102
DM1 model cells treated with replicative stressors produced instability of the ectopic site
(CTG)·(CAG) repeats. These results open the possibility that replication restart during
repeated cycles of replicative stress and recovery induces a different pattern of instability
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than continuous replication stress. Additionally, we show a new mechanism for
microsatellite instability, double strand break formation. Classically, instability of
microsatellite sequences was determined by the expansion or contraction in the number
of (CTG)·(CAG) repeats (Fernandez-Lopez et al., 2004; McMurray, 2010; Zeman and
Cimprich, 2014).
In addition to (CTG)102·(CAG)102 repeats, we also examined the effect of loss of
FANCJ on (CTG)12·(CAG)12 repeats with the treatment of aphidicolin. Surprisingly, this
normal repeat length was also unstable under these conditions. These results suggest
FANCJ is necessary for the stability of all microsatellite sequences pathological and
nonpathological increasing the importance in understanding the mechanism behind this
phenomenon.
We observed a difference in sensitivity to FANCJ helicase depletion and
aphidicolin treatment between (CTG)n and (CAG)n cells. Irrespective of (CTG)·(CAG)
repeat length, (CAG)n cells were more sensitive to aphidicolin and FANCJ helicase
depletion compared to (CTG)n cells. This observation has also been seen by other
researchers in the laboratory. We believe this different in sensitivity leads to the
variability in small pool PCR signal loss at the ectopic site (CTG)n·(CAG)n repeats
between (CAG)n cells and (CTG)n cells.

FANCJ is essential for microsatellite stability across the genome
Trinucleotide repeats consisting of (CTG)·(CAG) sequences represent only one
subset of microsatellite sequences. Other subtypes of microsatellites varying in length
and nucleotide composition exist. Collectively, microsatellites make up approximately
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3% of the entire genome. Surprisingly, multiple endogenous microsatellites showed
instability with the depletion of FANCJ helicase and presence of aphidicolin or
hydroxyurea in CAG102 cells. The same endogenous microsatellites were also unstable in
FANCJ null fibroblast cells exposed to replication stress indicating microsatellite
instability is not limited to (CTG)·(CAG) trinucleotide repeats but transpires at diverse
microsatellite sequences. FANCJ null cells complemented with FANCJ wild-type cDNA
rescued the phenotype of microsatellite instability under replication stress in FANCJ null
cells solidifying a role for FANCJ helicase in microsatellite stabilization across the
genome during replication stress. Previous work has shown that FANCJ null cells exhibit
an increased level of chromosomal abnormalities when exposed to naturally occurring
replication stress (Kuzminov, 2013; Noda et al., 2011), therefore, our work suggests
diverse microsatellites are inherently prone to breakage and FANCJ is required for the
prevention of double strand break formation during natural replication stress. Further,
these results raise the question of whether there is a common intermediate, such as a
stalled replication fork, which leads to double strand breaks. Additionally, our results
suggest that microsatellite instability can be used as diagnostic tool to assay for FANCJ
deficiency.
We noticed differences in the extent of small pool PCR signal loss between
microsatellite sequences across the genome. The stability of secondary (non-B form)
DNA structures varies (Bochman et al., 2012). We suspect the difference in stability
between hairpins, triplexes, G-quadruplexes and other non-B form structures leads to
differential small pool PCR signal loss.
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Recently, a FANCJ helicase null mouse was created. Mouse embryonic
fibroblasts (MEFs) from the knockout mouse model for FANCJ helicase show increased
sensitivity to aphidicolin when compared to FANCJ proficient controls (Matsuzaki et al.,
2015). Additionally, genomic instability is observed at a number of microsatellite
sequences across the genome, homologous murine microsatellites sites to microsatellites
sites we conveyed (Matsuzaki et al., 2015), confirming our results suggesting FANCJ is
necessary for microsatellite stabilization during replication stress.

DSBs induced by depletion of FANCJ and replicative stress lead to G2/M
arrest
Experiments presented in this work were conducted in the presence of a low dose
of aphidicolin or hydroxyurea that does not acutely activate the DNA checkpoint
response (Casper et al., 2002; Chen et al., 2015; Glover et al., 1984; Petermann et al.,
2010; Wist, 1980). However, we examined the cell cycle profiles of FANCJ null cells
and HeLa cells treated with siControl or siFANCJ exposed to aphidicolin and determined
that the cells depleted of FANCJ are more sensitive to aphidicolin treatment.
Additionally, FANCJ null cells treated with aphidicolin accumulated in the G2/M phase
of the cell cycle indicative of a DNA checkpoint response. Previously published data of
cell cycle profiles from normal fibroblast cells treated with aphidicolin show a slower
progression through S phase indicative of aphidicolin affecting replication polymerases
(Mao et al., 2008b). Here we show the additive loss of FANCJ helicase, in FANCJ null
cells, leads to a different cell cycle profile, in which cells stall in the G2/M phase.
Experiments are under way in the laboratory to assess the phosphorylation status of the
DNA checkpoint kinase 1 (Chk1) and checkpoint kinase 2 (Chk2) as well as the kinases
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upstream of Chk1 and Chk2, Ataxia telangiectasia mutated (ATM) and Ataxia
telangiectasia and Rad3 related kinase (ATR) to understand the mechanism of checkpoint
activation in cells depleted of FANCJ under replication stress.

FANCJ functions independently of the FA repair pathway
FANCJ is the helicase associated with the FA repair pathway. Activation of the
FA repair pathway occurs in response to replication stress and DNA damage. The
requirement of FA repair pathway activation for FANCJ to stabilize microsatellites was
examined. Knockdown of FANCM and FANCD2 in (CTG)102·(CAG)102 DM1 model
cells exposed to replicative stress does not lead to instability of ectopic site
(CTG)·(CAG) repeats or endogenous microsatellites suggesting FANCJ functions
independently of the FA repair pathway to maintain microsatellite stability. FANC null
patient cells treated with either aphidicolin or hydroxyurea to induce replication stress
show a similar pattern of instability at all endogenous microsatellites analyzed
confirming FANCJ helicase stabilizes microsatellites irrespective of activation of the FA
repair pathway. A concern of the experimental approach may be that instability is
occurring and goes undetected by our end-point PCR approach. Endogenous sites and the
ectopic site were examined in multiple FANC null protein conditions both with and
without replicative stress. Small pool PCR results under all combination of conditions
(different FANC protein null cells treated with aphidicolin or hydroxyurea) did not show
variability in results, no loss in spPCR signal. If instability was taking place, it is likely
that we would have observed inconsistencies in small pool PCR results. In addition, we
performed a small pool PCR titration experiment in which we varied the ratio of copy
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number between the ectopic site and an internal control site. It was evident that loss of
PCR signal is detectable via our end-point small pool PCR method.
Recently, a number of FANC proteins have been implicated in DNA replication
and repair processes independent of the FA repair pathway, as we have shown for
FANCJ. To begin, FANCM functions with associated protein FAAP24 to recognize
DNA damage and mediate the Ataxia telangiectasia and Rad3 related kinase (ATR)/
checkpoint kinase 1 (Chk1) checkpoint response to prevent accumulation of unrepaired
DNA damage independent of the FA core complex (Collis et al., 2008; Schwab et al.,
2010; Wang et al., 2013). In addition, ATR-mediated replication fork restart is deficient
in FANCM null cells when compared to other FANC null cells (FANCC and FANCI)
(Schwab et al., 2010). Phosphorylation of FANCI by ATR in response to replication
stress leads to dormant origin firing and replication fork restart (Chen et al., 2015).
FANCD2 functions with BLM helicase to promote replication fork recovery
independently of FANCI and the FA pathway (Chaudhury et al., 2013). Most recently,
FANCD2, FANCD1/BRCA2, and FANCJ have been implicated in replication fork
recovery after treatment with aphidicolin or hydroxyurea independently of the FA core
complex (Raghunandan et al., 2015). Taken together, it is not surprising FANCJ
functions irrespective of FA repair pathway activation. FANCM, FANCI, FANCD2, and
FANCD1/BRCA2 depleted or null cells were treated with aphidicolin and hydroxyurea.
Microsatellite instability was not detected under these conditions suggesting the FA
independent roles of other FANC proteins are also not essential for FANCJ to stabilize
microsatellites further confirming a uniquely novel function for FANCJ helicase in the
protection of microsatellite integrity.
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Coupled with recent work from MEFs from FANCJ helicase null mice
(Matsuzaki et al., 2015), our results suggest FANCJ helicase functions independently of
the FA repair pathway to stabilize microsatellite sequences. We suspect FANCJ functions
in different DNA repair processes based upon interaction with different repair proteins.
For function in the FA repair pathway FANCJ requires helicase activity and interaction
with BRCA1 (phosphorylation at serine 990). However, for stabilization of
microsatellites, FANCJ does not rely on activation of the FA repair pathway.

Translocations occur in FANCJ depleted cells during replicative stress
(CTG)102·(CAG)102 DM1 model cells depleted of FANCJ helicase and treated
with aphidicolin resulted in (CTG)·(CAG) trinucleotide repeat stability. Interestingly,
sequences 1-3kb from the (CTG)·(CAG) repeats of the ectopic site remained intact while
primers <100 bp from the repeats did not give a PCR product. These data suggested the
primer binding sites used for spPCR are no longer in close proximity to one another,
which would result from a double strand break (DSB). To determine if double strand
breaks lead to translocations and where those translocations are located, we employed an
inverse PCR (iPCR) approach. Long distance iPCR has previously been used to identify
translocations in cancer cells and many reports have discussed importance of iPCR
approaches to determine unknown translocation sites (Benkel and Fong, 1996; Ochman et
al., 1988; Schneider et al., 2011) supporting iPCR as a good technique to determine
translocations at the ectopic site. Coupling iPCR with next generation sequencing (Meier
and Gartner, 2014) proved to be the ideal application. Inverse PCR results revealed that
translocations occurred between the ectopic site (CTG)·(CAG) repeats and another
genomic site. Translocation sites determined by iPCR have been identified
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cytogenetically. The cytogenetic positions of all the translocation sites we have identified
have previously been associated with chromosome instability, cancer, and developmental
disorders. Chromosome 2p22.3 is linked to small cell lung carcinoma (Lui et al., 2001),
sesorineural nonsyndromic recessive deafness (Chaib et al., 1996), and Maffucci
syndrome (development of multiple enchondromas associated with hemangiomas,
predisposed to CNS, pancreatic, and ovarian malignancies) (Amyere et al., 2014). In
addition, chr. 2q12.2 is associated with small cell lung carcinoma (Lui et al., 2001) and
chr. 2q34 with breast cancer (Kim et al., 2012) and Bjornstad syndrome (developmental
disorder associated with deafness) (Lubianca Neto et al., 1998). Ovarian cancer
(Kamieniak et al., 2015; Wan et al., 1999), breast cancer (Li et al., 2007), neuroblastoma
(Li et al., 2007), and melanoma (Li et al., 2007) have been linked to chr. 6q24.1.
Chromosome 7p15.3 is connected with multiple disorders including Dandy Walker
syndrome (brain malformations) (Chen et al., 2010), hand-foot-genital syndrome (limb
malformations and urogenital abnormalities) (Hosoki et al., 2012), myeloma (Broderick
et al., 2012; Martino et al., 2012; Weinhold et al., 2015), childhood lymphoma/leukemia
(Kaneko et al., 1988) and ovarian cancer (Li et al., 2014; Shimada et al., 2013).
Chromosome 8q24.21 associates with gliomas (Enciso-Mora et al., 2013; Lu et al., 2015),
renal cell carcinoma (Gudmundsson et al., 2013), male breast cancer (Silvestri et al.,
2015), lymphoma (Enciso-Mora et al., 2010), and T-cell leukemia (Crowther-Swanepoel
et al., 2010). Chromosome 10q22.3 is linked to Cowden disease (growth of multiple
hamartomas and increased risk of cancer) (Nelen et al., 1996), breast cancer (Chen et al.,
2012; Kiyotani et al., 2012), ovarian cancer (Ho et al., 2009), non-small cell lung cancer
(Petersen et al., 1998; Yendamuri et al., 2008), and prostate cancer (Lu and Hano, 2008;
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Pan et al., 2001). Chromosome 11p15.4-5 relates to breast cancer (Wikman et al., 2012),
Silver-Russell syndrome (delayed growth rate before and after birth) (Demars and
Gicquel, 2012; Eggermann et al., 2010), Beckwith Wiedemann syndrome (entire body
developmental abnormalities coupled with cancer predisposition) (Baskin et al., 2014;
Demars and Gicquel, 2012; Demars et al., 2011), and T lymphoid leukemia (Crescenzi et
al., 2015). Hepatocellular carcinoma (Wang et al., 2015b) and colorectal cancer
(Houlston et al., 2010) have been linked to chr. 20q13.13. We also note with interest that
a majority of the 300-500bp translocation site reads had a sequence predicted to form
noncanonical DNA structures, and are prone to double strand breaks in the absence of
FANCJ during replication stress from our studies, near the translocation junction (2p22.3
– G300; 2q12.2 – G4; 2q34 – G4; 7p15.3 – G4; 8q24.21 – G4; 11p15.4 – G4; 20q13.13 –
G4; 6q24.1 – T20; 19p13.32 – CTG20). We predict that DSBs form at microsatellite
sequences resulting in pools of free DNA ends which are substrates for classical DNA
repair pathways including non-homologous ending joining and microhomology-mediated
end joining, or form structures which cannot be resolved by classical DNA repair
processes. The high frequency of microsatellite DSBs in FANCJ depleted and null cells
during replication stress prompts us to consider that inherited or stochastic FANCJ
deficiency may pose a threat to proper replication of sequences known to form
noncanonical DNA structures resulting in chromosome aberrations. As a protector of
microsatellites, FANCJ possibly participates in the prevention of cancer and
developmental disorders broadening current understanding of FANCJ function.
Our data show double strand break formation at microsatellite sequences in cells
depleted of FANCJ helicase under replicative stress. The approach used in our
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experiments analyzes the repair of structure induced DNA breaks (double strand breaks
resulting from the presence of noncanonical DNA structures). The most common method
for identifying repair proteins and processes involved in the repair of double strand
breaks occurs through utilization of an I-Sce1 endonuclease restriction site (Choulika et
al., 1995; Liang et al., 1998). I-Sce1 recognizes and cuts DNA at an unique 18bp
sequence not found in the human genome (Monteilhet et al., 1990). An I-Sce1 expression
vector is co-transfected into cells with a plasmid containing a selectable marker that will
only express if homologous recombination occurs after I-Sce1 cleavage (Liang et al.,
1998). The level of selectable marker expression (fluorescence protein or resistance gene)
is measured and correlates to the amount of double strand breaks repaired by homologous
recombination (Liang et al., 1998). Coupling this technique with the knockdown of
replication and repair proteins has identified many proteins that participate in
homologous recombination (Johnson et al., 1999; Liang et al., 1998; Pierce et al., 1999).
A similar system has been created to analyze nonhomologous end joining through I-Sce1
double strand break formation (Mao et al., 2008a). However, these approaches only
identify proteins involved in the repair of a controlled, direct double strand break
produced by I-Sce1 cleavage. Only recently has structure induced breaks been examined.
Carboxyterminal binding protein-interacting protein (CtIP) has been identified in the
protection of common fragile sites and inverted repeat stability (Wang et al., 2014). This
report used an I-Sce1 experimental design, in which a structure forming sequence was
placed adjacent to the I-Sce1 cut site and noncanonical structure formation occurs after
cleavage by I-Sce1 (Wang et al., 2014). In comparison, our data show FANCJ helicase is
necessary in the prevention of structure induced double strand breaks. Additionally, the
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structure induced breaks naturally occur in our model, unlike controlled, direct breaks
created from I-Sce1 cleavage. Therefore, our approach offers a new method for
identifying replication and repair proteins essential for the resolution of structure induced
double strand breaks.
A large majority of next generation sequencing reads from iPCR containing
translocation sites mapped to the endogenous c-myc locus at chr. 8q24.21. The ectopic
site is located on chromosome 18 (Liu et al., 2003). Translocations from the ectopic site
c-myc core replicator to the endogenous c-myc locus occurred via non-allelic
homologous recombination. Coupled with the presence of microsatellite sequences at
other translocation sites, we propose that repair of DSBs formed at microsatellites is
nonrandom. However, it is possible that we are promoting nonrandom recombination
with the presence of the c-myc core replicator at the ectopic site. Further experiments are
underway to characterize translocations due to breaks at endogenous sites in a cell line
void of ectopic homologous sequences. For instance, restriction digestion, ligation and
iPCR followed by next generation sequencing of an endogenous microsatellite (i.e.
(CTG)·(CAG) repeats of the DMPK locus or ATTCT repeats of the SCA10 locus) in
FANCJ null cells treated with aphidicolin would be a good model. Results from these
experiments would determine if translocations occurring from DSBs at microsatellite
sequences show a similar propensity to repair the DSBs followed by translocation in an
orderly fashion via a subtype of recombination, or if we have exploited the model and
forced nonrandom recombination. Determining if the patterns of repair are different at
endogenous sites compared to the ectopic site is the goal. Additionally, we will determine
if the ectopic site (CTG)·(CAG) breaks induced breaks at endogenous microsatellite, or if
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endogenous microsatellite sequences break in the absence of FANCJ during replication
stress leaving a pool of broken DNA ends for repair by non-allelic homologous
recombination or microhomology-mediated end joining. Nonrandom repair would result
in translocations sites similar to the sites obtained from iPCR and NGS of the ectopic
(CTG)·(CAG) repeats. However, if a pool of DNA ends are created as a result of
replication stress in FANCJ null cells at microsatellite sequences and repair occurs
through microhomology-mediated end joining, we would expect the translocations sites
to differ between the ectopic site (CTG)·(CAG) repeats and the endogenous ATTCT
repeats of the SCA10 locus (or any other endogenous microsatellite sequence).
Lastly, the next generation sequencing data presented here represents only a small
subset of data obtained from the sequencer. The nucleotide positions of each end of the
reads (the first nucleotide and the last nucleotide of the read) containing translocation
junctions were used to identify the chromosome sites of translocations (as well as
cytogenetic positions). However, the exact breakpoint junctions were not identified.
Software exists to process deep sequencing data sets for breakpoint junctions including
Bellerophon (Hayes and Li, 2013), and we are currently using this software to narrow the
breakpoint junction sequences and determine whether translocation induces error-prone
break induced replication (BIR). Recently, computer software, SVDetect (Zeitouni et al.,
2010), was created to recognize genomic variations in the sequencing data. Analysis of
the sequencing data with Bellerophon and SVDetect, should provide insights into
breakpoint junction locations as well as mutations that arose during the transition of
double strand breaks to fused translocations.
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Microsatellite stabilization by FANCJ helicase is replication dependent
We have shown here a novel function for FANCJ helicase in microsatellite
stabilization during replicative stress. This novel function of FANCJ helicase is
independent of activation of the FA repair pathway. The microsatellite sequences
examined in this work vary in accessibility of proteins to chromatin. Some sequences are
replicated and transcribed increasing the length of time the DNA is exposed and other
sequences are not transcribed in HeLa cells, such as β-globin (Green et al., 1983). We
suspect small pool PCR signal loss across genome is a function of the entire genome
being replicated during the cell cycle supporting the notion that this novel function of
FANCJ helicase is replication dependent and independent of other cellular processes such
as transcription.

Replication fork regression vs. replication fork stalling
Our results identify a novel function for the FANCJ helicase in microsatellite
stabilization during replication stress. We have shown that double strand breaks form in
cells depleted of FANCJ under replicative stress. However, when the double strand break
occurs still remains unknown. The double strand break could form as a result of inability
to resolve a noncanonical DNA structure (London et al., 2008) at the microsatellite
sequence in the absence of FANCJ or through defective DNA repair mechanisms, since
FANCJ functions in replication fork regression (Brosh, 2013; Neelsen and Lopes, 2015;
Zellweger et al., 2015) and enables homologous recombination (Litman et al., 2005).
Understanding the mechanisms and identifying the proteins involved in supporting
FANCJ helicase to stabilize microsatellite sequences to protect genome stability is of
increasing interest. We would like to deplete proteins whose functions are specific to fork
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regression or homologous recombination in the presence of replication stress and
examine microsatellite stability to determine the proteins functioning in signaling
cascades necessary for FANCJ helicase to prevent microsatellite instability.
Additionally, we propose to examine FANCJ helicase activity in replication fork
regression and replication fork stalling via density-gradient separation of
bromodeoxyuridine (BrdU) labelled DNA coupled with chromatin immunoprecipitation
(ChIP). BrdU labelled DNA strands are heavier than that of unlabeled DNA strands
(Painter and Cleaver, 1969). BrdU is incorporated into nascent DNA strands during DNA
replication creating labelled DNA. Unlabeled DNA strands are referred to as light strands
and BrdU labelled DNA strands are termed heavy strands. Possible combinations double
strand DNA comprised of light strands and heavy strands have the following densities:
light - light strand has the density of 1.716 to 1.722 g/cm3, heavy - light strands density
are between 1.755 to 1.761 g/cm3, and heavy - heavy strands have a density between
1.821 to 1.831 g/cm3 (Painter and Cleaver, 1969). Coupling BrdU labelling of DNA with
ChIP specifies the DNA sequences of interest. Pulldown of FANCJ helicase after BrdU
labelling would reveal only the sequences linked to FANCJ helicase (DNA sequences of
interest) while discarding other DNA sequences. Reversal of crosslinking between DNA
to protein, frees the DNA sequences for separation. A stalled replication fork would
contain light-light or heavy-light DNA (Figure 63). However, replication fork regression
occurs in response to DNA damage in which replication is reversed resulting in rereplication of the nascent strand DNA producing heavy-heavy DNA (Figure 63).
Comparing the composition of DNA pulled down with FANCJ during replication stress
will provide insights into the presence of FANCJ helicase at stalled replication forks or
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Figure 63. Proposed roles for FANCJ in replication fork stalling and
regression. FANCJ helicase may function in either replication fork stalling or
replication fork regression. Utilizing BrdU to label nascent strand DNA during
replication stress with help determine which process FANCJ functions in and if
these processes occur at microsatellite sequences.
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regressed replication forks. For additional comparison, DNA sequences pulled down with
BRCA2 will serve as an example for replication fork stalling, since BRCA2 has been
shown to protect replication forks from stalling previously (Lomonosov et al., 2003;
Schlacher et al., 2011; Ying et al., 2012). After separation of labelled and unlabeled DNA
sequences by density, individual groups of DNA sequences (light-light, heavy-light or
heavy-heavy) could be subjected to quantitative PCR (qPCR) to determine the abundance
of microsatellite sequences present in each category. A greater abundance of
microsatellite sequences in either heavy-light or heavy-heavy DNA depending on the
process, replication fork stalling or replication fork regression respectively, disrupted in
microsatellite instability in the absence of FANCJ helicase during replicative stress is
expected.

FANCJ stabilizes microsatellites independent of BLM/WRN activity
Current models of genome stabilization by helicases whose dysfunction leads to a
genome instability disorder suggest a cooperative mechanism in which FANCJ unwinds
noncanonical DNA structures in a 5’ to 3’ orientation while BLM helicase or WRN
helicase unwind non-B form structures in a 3’ to 5’ orientation. Function of both
direction specific helicases is necessary for proper structure resolution leading to error
free DNA replication and repair. Knockdown of BLM helicase in (CTG)102·(CAG)102
DM1 model cells under replication stress did not produce microsatellite instability
suggesting the activity of BLM helicase is nonessential for FANCJ to maintain
microsatellite stability. Similar results were obtained in BLM helicase null patient cells
treated with either aphidicolin or hydroxyurea suggesting indeed FANCJ stabilizes
microsatellites independently of BLM helicase activity. Furthermore, the treatment of a
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Fanconi anemia patient cell harboring the homozygous FANCJR798X mutation eliminating
BLM helicase interaction with aphidicolin or hydroxyurea also did not result in
microsatellite instability further confirming BLM function remains dispensable in
microsatellite stabilization by FANCJ helicase.
Knockdown of WRN helicase in (CTG)102·(CAG)102 DM1 model cells exposed
to aphidicolin showed no instability at microsatellites indicating WRN activity is
nonessential for FANCJ helicase to maintain chromosome stability. WRN null cells
treated with either aphidicolin or hydroxyurea confirmed results depicting no
microsatellite instability further confirming FANCJ helicase functions to stabilize
microsatellites irrespective of WRN helicase activity. Considering the data presented
regarding depletion of BLM helicase and WRN helicase, our data suggest an unique
function for FANCJ helicase separating FANCJ from previously proposed models of
cooperative activity with BLM helicase and WRN helicase.
BLM helicase and WRN helicase belong to the RecQ family of helicases along
with RECQL4 (associated with Rothmund Thomson syndrome) (Kitao et al., 1999;
Nakayama, 2002). Recent work has indicated redundancy exists in the function of this
family of helicases (Sidorova et al., 2013; Sturzenegger et al., 2014). BLM helicase and
WRN helicase function additively promotes replication fork progression (Sidorova et al.,
2013). Additionally, WRN helicase can substitute for BLM helicase during the DNA
damage response for DNA end resection catalyzed by DNA2 (Sturzenegger et al., 2014).
Here, we have examined the loss of BLM helicase and WRN helicase during replicative
independently. It would be interesting to knockdown BLM helicase and WRN helicase
simultaneously during replication stress, since these redundancies exist within the RECQ
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family of helicases. However, we suspect no microsatellite instability would be observed
similar to the loss of BLM helicase and WRN helicase individually. Initially,
microsatellite stabilization during replication stress appeared to be 5’ to 3’ helicase
specific.

FANCJ-like family of DNA helicases
Based on our data, we suspected microsatellite stability during replication stress
relies on the activity of a 5’ to 3’ unwinding enzyme irrespective of 3’ to 5’ unwinding
helicase activity. However, this work only examines the loss of FANCJ on microsatellite
stabilization during replicative stress. A new family of helicases has emerged with
sequence homology to FANCJ helicase (Wu et al., 2009). Helicases of this FANCJ-like
family include XPD, ChiR1/DDX11, and RTEL1 (Wu et al., 2009). All members of this
family of helicases share a conserved helicase core domain (Wu et al., 2009) (Figure 64).
XPD helicase functions in nucleotide excision repair (Fan et al., 2008). ChiR1/DDX11
helicase promotes sister chromatin cohesion (Wu et al., 2012). Lastly, the helicase
RTEL1 helicase unwinds noncanonical DNA structures including G-quadruplexes
formed at telomeres, is essential for trinucleotide repeat integrity, and is thought to
promote genome stability in cancer cells through the suppression of homologous
recombination (Barber et al., 2008; Frizzell et al., 2014; Uringa et al., 2011; Vannier et
al., 2014). Redundancy between the functions of these helicases may exist due to
sequence homology of the catalytic helicase domain. It is likely these helicases have
similar function to FANCJ helicase in response to replicative stress. We suspect the loss
of XPD, ChiR1/DDX11, or RTEL1 coupled with replication stress would lead to
microsatellite instability as seen with the loss of FANCJ helicase. We propose that
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Figure 64. FANCJ-like family of helicases. The FANC-like family of DNA
helicases includes XPD, ChiR1, and RTEL1. A conserved helicase core domain is
shared among all family members (blue bar). (Adapted from Wu et al., 2009)
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microsatellite stabilization during replicative stress is a function of the FANCJ-like
family of helicases.

5’ to 3’ unwinding DNA helicases similar to FANCJ helicase
Other 5’ to 3’ unwinding helicases that do not belong to the FANCJ-like family of
helicases exist including Pif1 and Fbh1. Pif1 has been implicated in promoting the
stability of G4 DNA, G-quadruplex forming DNA, at telomeres in human cells (Paeschke
et al., 2011; Sanders, 2010). In addition, evidence exists to suggest Pif1 helicase function
is important for resolving intermediates formed during replication and G-quadruplex
structures formed at a guanine rich sequences at the HECT and RLD domain containing
E3 ubiquitin protein ligase 5 (CEB1) locus (Paeschke et al., 2011; Pike et al., 2010;
Ribeyre et al., 2009). Recent reports indicate the helicase Fbh1 localizes at DNA damage
sites in response to accumulation of single strand DNA to promote replication fork
regression and homologous recombination repair of DNA lesions (Chu et al., 2015;
Fugger et al., 2009; Fugger et al., 2015). Since Pif1 and Fbh1 possess roles in DNA
replication and repair similar to FANCJ helicase, it is possible these helicases also
function in microsatellite stabilization during replication stress. We suspected
microsatellite stabilization under replicative stress is a function of 5’ to 3’ DNA helicases
who function in DNA replication or repair due to overlap in function between FANCJ
and Pif1 or Fbh1. However, treatment of cells harboring a biallelic FANCJR798X mutation,
which renders the protein helicase dead in vitro, with replication stressors aphidicolin or
hydroxyurea revealed no loss of small pool PCR signal suggesting the helicase function
of FANCJ is dispensable for microsatellite stabilization. Therefore, protection of
microsatellite stability during replication stress is likely not a function of all 5’ to 3’
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helicases and is specific to FANCJ helicase and possibly other members of the FANCJlike family of helicases.

FANCJR798X mutant offers insights into functional domains of FANCJ
The most commonly occurring FANCJ mutation is R798X which produces a
premature stop codon on the FANCJ transcript subsequently truncating the protein. This
truncation eliminates binding sites for BRCA1, TopBP1 and BLM. Additionally, in vitro
analysis of FANCJR798X indicated a loss of helicase activity. We examined the effect of
truncating FANCJ by treating a Fanconi anemia complementation group J patient cell
line harboring a homozygous FANCJR798X mutation with aphidicolin or hydroxyurea.
Interestingly, microsatellite instability was not seen under these conditions. These results
suggest BRCA1, TopBP1 and BLM binding or FANCJ helicase activity are not essential
for FANCJ to maintain microsatellite stabilization. FANCJ interacts with other proteins
necessary for DNA replication and DNA damage responses including Mre11 and the
MRN complex (Suhasini et al., 2013), RPA (Gupta et al., 2007) and MLH1 (Peng et al.,
2007). Recently, proteins containing iron-sulfur (Fe-S) clusters are of interest. The Fe-S
cluster of multiple proteins has been implicated in genome stability through function in
mitochondrial respiration and DNA repair (Beilschmidt and Puccio, 2014; Paul and Lill,
2014). FANCJ has a Fe-S cluster and this domain is essential for helicase activity (Rudolf
et al., 2006; White, 2009). These domains, which are present in the truncated
FANCJR798X mutant, may be essential for FANCJ to function in stabilization of
microsatellites.
Several groups have published on the inability to detect the FANCJR798X truncated
mutant in vivo (Cantor and Guillemette, 2011; Litman et al., 2005). Experiments are
153

underway in our laboratory to create an epitope tagged FANCJR798X mutant protein for
the detection of the mutant protein via Western blot, and examine its in vivo function.
Expression of a tagged version of FANCJR798X in FANCJ null cells could be used in
rescue experiments to determine if the domains present in the truncated protein are
sufficient for FANCJ to stabilize microsatellites. We suspect these experiments will offer
insights into the mechanism behind FANCJ function in promoting microsatellite stability.
As previously stated, recombinant FANCJR798X helicase does not retain helicase activity
in vitro. However, it is unclear if FANCJR798X helicase remains inactive in vivo. To
confirm helicase function is dispensable for FANCJ to maintain microsatellite stability,
mutation of lysine 52 to arginine on FANCJ (Cantor et al., 2001) could be performed.
This residue is critical for ATPase hydrolysis and mutation leads to dysfunction of
helicase activity (Cantor et al., 2004; Cantor et al., 2001; Gupta et al., 2005). Expression
of FANCJK52R in FANCJ null cells under replication stress would aid in understanding
the role the helicase domain has in microsatellite stabilization. If it is determined that the
helicase activity of FANCJ is not essential for microsatellite stability, it is likely FANCJ
functions as a signal for the recruitment of other repair proteins. Additionally, FANCJlike helicase family members who have conserved regions of homology may also
function as a signaling molecular similar to FANCJ helicase; therefore, the loss of these
helicases during replication stress is of interest as well.
As previously stated, FANCJ helicase may function in different repair processes.
In the FA repair pathway, FANCJ utilizes interaction with BRCA1 and helicase function
to aid DNA repair. Here, we show a second cellular process FANCJ functions in,
microsatellite stabilization during replication stress. For microsatellite stabilization,
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FANCJ function independent of interactions with BRCA1, TopBP1 and BLM helicase,
activation of the FA repair pathway, and additionally, helicase activity is unessential.

Possible mechanisms for FANCJ mediated microsatellite stabilization
This work has not focused on a mechanism of action for FANCJ helicase in
microsatellite stabilization. However, we have shown functional domains not essential for
is this function of FANCJ helicase (i.e. BRCA1, TopBP1, and BLM helicase interaction).
Therefore, we propose three possible mechanisms of action: (i) The FANCJR798X
truncation mutations of FANCJ retains interaction sites for MLH1 and interaction with
MLH1 and other mismatch repair proteins may lead to the recruitment of FANCJ to
microsatellite sequences. (ii) Previously published work from other researchers has
identified interaction of Mre11 and RPA with FANCJ. However, the domains necessary
for these interactions on FANCJ are unknown. It is possible that FANCJ is utilizing
interaction with Mre11 or RPA for recruitment to the site of DNA damage. (iii) It is
possible that FANCJ helicase is traveling with the replication fork during replication
through an unknown interaction with the replisome. Recently, it was determined that
RTEL1, a FANCJ-like helicase family member, directly interaction with proliferating cell
nuclear antigen (PCNA) during replication and promotes proper DNA replication,
replication stability, and telomere stability (Vannier et al., 2013). Therefore, it is possible
FANCJ also interacts with the replisome. To understand the mechanism of action for
FANCJ helicase in microsatellite stabilization during replication stress, these avenues
must be examined. First, mutation of MLH1 binding domains on FANCJ would identify
the necessity for MLH1 binding. Second, identification of Mre11 and RPA binding sites
on FANCJ would add insight into the dependency on Mre11 and RPA interaction for
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FANCJ to stabilize microsatellite sequences. Lastly, immunoprecipitation followed
analysis with mass spectroscopy would determine other possible unknown interactions
between FANCJ and other replication and repair proteins offering insights into the
mechanism behind microsatellite stability by FANCJ helicase.

Dog-1 as an alternate to FANCJ helicase in microsatellite stabilization
The C. elegans orthlog of FANCJ, dog-1 (Youds et al., 2008), has previously
been associated with the stabilization of G4 DNA sequences (thought to fold into the
non-B form structure G-quadruplex) (Cheung et al., 2002; Kruisselbrink et al., 2008).
Comparison of amino acid sequences of FANCJ and dog-1 revealed a conserved helicase
domain between both proteins (Figure 65). In addition, the C-terminus of the FANCJ is
not present in dog-1. The C-terminus includes interaction sites with BLM helicase,
BRCA1, and TopBP1. These domains are eliminated in the truncation, R798X, mutation
of FANCJ. Interestingly, this mutation was sufficient to protect against microsatellite
instability. These results concur with results from experiments examining dog-1. Full
length dog-1 (the same domains are present in the R798X mutation of FANCJ) stabilizes
G4 DNA sequences. However, loss of dog-1, comparable to FANCJ null cells void of
FANCJ, shows deletions of sequences flanking G4 DNA supporting the results we have
shown confirming a role for FANCJ helicase in microsatellite stability. We hypothesize
that expression of dog-1 in FANCJ null cells would be adequate to rescue microsatellite
instability during replication stress. Additionally, mutation of other domains still present
in the FANCJR798X would lead to identification of functional domains necessary for
microsatellite stabilization.
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Figure 65. Amino acid comparison of FANCJ and dog-1. A conserved helicase
core domain (blue bar) is present in both human FANCJ helicase and the C. elegans
ortholog, dog-1. (Adapted from Wu et al., 2009)
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FANCJ helicase function in cancer
Recent work has identified a variety of separation of function FANCJ mutations.
Figure 66 depicts a schematic of FANCJ mutations associated with breast cancer only,
Fanconi anemia only, or both breast cancer and Fanconi anemia supporting distinctly
different roles for FANCJ associated with a diverse variety of pathologies from cancer to
developmental disorders (Cantor and Guillemette, 2011). It is likely that inability of
FANCJ to stabilize microsatellites accompanies a subset of FANCJ mutations.
Examining additional pathological FANCJ mutations is of interest to separate function in
the FA repair pathway from the protection of microsatellite stability.

FANCJ helicase as a cancer therapeutic target
In addition to Fanconi anemia, mutation or loss of FANCJ helicase has been
linked to susceptibility of multiple cancers including breast cancer (Cantor and
Guillemette, 2011; De Nicolo et al., 2008; Eelen et al., 2008; Guenard et al., 2007),
ovarian cancer (Kuusisto et al., 2011; Rafnar et al., 2011), colon cancer (Nakanishi et al.,
2012; Xie et al., 2010), and prostate cancer (Kote-Jarai et al., 2009). Multiple groups
have referred to FANCJ helicase as a genomic caretaker and tumor suppressor (Cantor
and Guillemette, 2011; De Nicolo et al., 2008; Peng et al., 2007; Wu et al., 2008). We
believe our findings offer an advantageous approach to the development of new therapies
to combat FANCJ helicase associated disorders. We suspect FANCJ helicase is a
potential therapeutic target for the treatment of many cancers. A combinational approach
could be developed in which FANCJ inhibition occurs during treatment with replication
stress inducing reagents to produce genome instability. Small molecule inhibitors could
be used to block FANCJ function followed by treatment with replication inhibitors to
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Figure 66. Schematic of FANCJ mutations associated with disease. Mutations in
FANCJ that are linked to breast cancer (blue), Fanconi anemia (pink) or breast
cancer and Fanconi anemia (purple). (Adapted from Cantor and Guillementte, 2011)

159

slow the growth of tumors. Recently, a small molecule inhibitor was created to inhibit the
activity of WRN helicase (Aggarwal et al., 2011). Treatment of HeLa cells with the small
molecular inhibitor resulted in increased DNA damage and inhibition of cell proliferation
(Aggarwal et al., 2011). Additionally, a recent report showed that decreased levels of
FANCJ sensitized gastric cancer cells to oxalipalatin (platinum based chemotherapeutic)
(Mori et al., 2013) supporting our hypothesis of combinational therapy to damage and
ultimately destroy cancer cells. Coupling the loss of FANCJ function (through gene
therapy or small molecule inhibitors) with a DNA damaging drug could be a novel
therapeutic approach for the treatment of FANCJ associated cancers (breast, ovarian,
prostate, and colon).
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FUTURE DIRECTIONS
The work presented in this dissertation identifies a novel function for the FANCJ
helicase in microsatellite stabilization during replication stress. To move forward with the
project, we are currently creating epitope tagged expression plasmids for wild-type and
mutant FANCJ helicase. The mutant constructs include disruption of MLH1 binding, the
FANCJR798X mutation to determine if a truncated protein is expressed in vivo, and a
catalytically inactive helicase domain created by a point mutation at lysine 52. The goal
of mutagenizing FANCJ helicase focuses on determining the mechanism of action for
FANCJ helicase in microsatellite stabilization. Additionally, we are performing
endonuclease digestion, intramolecular ligation and inverse PCR at an endogenous
microsatellite sequence ((CTG)19 repeats of the DMPK locus and (ATTCT)13 repeats of
the SCA10 locus) in FANCJ null cells treated with aphidicolin. We are interested in
understanding the mechanisms behind repair of double strand breaks at microsatellite
sequences in cells depleted of FANCJ helicase under replicative stress. We are
determining the phosphorylation status of checkpoint kinases including ATR, ATM,
Chk1, and Chk2 to determine the mechanism of G2/M accumulation over time during
aphidicolin treatment in FANCJ null cells. Lastly, we are using Bellerophon software to
determine the exact breakpoint junctions from the inverse PCR next generation
sequencing data. In addition, SVDetect will be used to understand the mechanisms used
for repair and if repair occurred in an error-free process.
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CONCLUSION
The work presented in this document focuses on identifying a novel function for
the FANCJ helicase in stabilization of microsatellites. Stabilization of microsatellites by
FANCJ occurs independently of the FA repair pathway and BLM helicase/WRN helicase
activity. Double strand breaks form at the microsatellites resulting in translocations in
FANCJ depleted cells during replication stress. Inverse PCR coupled with next
generation sequencing provided a link between FANCJ function in microsatellite stability
and a variety of cancers and developmental diseases suggesting a role for FANCJ in other
disorders aside from Fanconi anemia. These data expand the current model of FANCJ
function while opening a new avenue of diagnostic tool development for FANCJ
insufficiency.
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